PMC4040184 1. Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management.
Abdom Imaging 2014; 39 (3): 588-604 jinzaki@rad.med.keio.ac.jp.
*24504542* 24504542 PMC4040183 2. Revisiting morphine-augmented hepatobiliary imaging for diagnosing acute cholecystitis: the potential pitfall of high false positive rate.
Abdom Imaging 2014; 39 (3): 467-71 bortau@adm.cgmh.org.tw.
*24402474* 24402474 PMC3682683 3. Emergency ultrasound-assisted examination of skin and soft tissue infections in the pediatric emergency department.
Acad Emerg Med 2013; 20 (6): 545-53 jennifer.marin@chp.edu
*23758300* 23758300 PMC3945039 4. Assessing splenomegaly: automated volumetric analysis of the spleen.
Acad Radiol 2013; 20 (6): 675-84 mlingura@cnmc.org
*23535191* 23535191 PMC4063495 5. Exercises in molecular computing.
Acc Chem Res 2014; 47 (6): 1845-52
*24873234* 24873234 PMC4072702 6. Surface molecular tailoring using pH-switchable supramolecular dendron-ligand assemblies.
ACS Appl Mater Interfaces 2014; 6 (9): 6264-74
*24742280* 24742280 PMC4068217 7. An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
ACS Chem Biol 2014; 9 (6): 1251-6
*24669831* 24669831 PMC3773059 8. An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.
ACS Chem Biol 2013; 8 (6): 1324-34
*23614352* 23614352 PMC4013547 9. Structure of Enterococcus faeciuml,d-transpeptidase acylated by ertapenem provides insight into the inactivation mechanism.
ACS Chem Biol 2013; 8 (6): 1140-6
*23574509* 23574509 PMC3745995 10. Persulfide reactivity in the detection of protein s-sulfhydration.
ACS Chem Biol 2013; 8 (6): 1110-6
*23557648* 23557648 PMC3744587 11. Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury.
ACS Chem Biol 2013; 8 (6): 1283-90
*23547844* 23547844 PMC3755046 12. Facilitating cytokine-mediated cancer cell death by proteobacterial N-acylhomoserine lactones.
ACS Chem Biol 2013; 8 (6): 1117-20
*23517377* 23517377 PMC3708293 13. Selective catecholamine recognition with NeuroSensor 521: a fluorescent sensor for the visualization of norepinephrine in fixed and live cells.
ACS Chem Neurosci 2013; 4 (6): 918-23
*23527575* 23527575 PMC3689194 14. ClC-3 is an intracellular chloride/proton exchanger with large voltage-dependent nonlinear capacitance.
ACS Chem Neurosci 2013; 4 (6): 994-1003
*23509947* 23509947 PMC3756451 15. Tanshinones inhibit amyloid aggregation by amyloid-beta peptide, disaggregate amyloid fibrils, and protect cultured cells.
ACS Chem Neurosci 2013; 4 (6): 1004-15
*23506133* 23506133 PMC3689192 16. A calcium-relay mechanism in vertebrate phototransduction.
ACS Chem Neurosci 2013; 4 (6): 909-17 karl.w.koch@uni-oldenburg.de
*23472635* 23472635 PMC3689193 17. Biological activity of sym-triazines with acetylcholine-like substitutions as multitarget modulators of Alzheimer's disease.
ACS Chem Neurosci 2013; 4 (6): 924-9
*23472585* 23472585 PMC3689190 18. Improved orange and red Ca(2)+/- indicators and photophysical considerations for optogenetic applications.
ACS Chem Neurosci 2013; 4 (6): 963-72
*23452507* 23452507 PMC3689191 19. Abeta42-binding peptoids as amyloid aggregation inhibitors and detection ligands.
ACS Chem Neurosci 2013; 4 (6): 952-62
*23427915* 23427915 PMC3689202 20. The molecular basis of memory. Part 2: chemistry of the tripartite mechanism.
ACS Chem Neurosci 2013; 4 (6): 983-93 gerardmarx@gmail.com
*23419130* 23419130 PMC3689195 21. Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies.
ACS Chem Neurosci 2013; 4 (6): 973-82
*23414128* 23414128 PMC4053090 22. Utility of redundant combinatorial libraries in distinguishing high and low quality screening hits.
ACS Comb Sci 2014; 16 (6): 259-70
*24749624* 24749624 PMC4027141 23. Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold.
ACS Med Chem Lett 2013; 4 (5): 491-6
*24900696* 24900696 PMC4027511 24. Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators.
ACS Med Chem Lett 2013; 4 (5): 475-80
*24900695* 24900695 PMC4027145 25. Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development.
ACS Med Chem Lett 2013; 4 (5): 466-9
*24900694* 24900694 PMC4027563 26. PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of beta-Amyloid Plaques.
ACS Med Chem Lett 2013; 4 (5): 436-40
*24900692* 24900692 PMC4027573 27. Dihydrooxazines As Inhibitors of BACE-1 or BACE-2.
ACS Med Chem Lett 2013; 4 (5): 433-4
*24900690* 24900690 PMC4027248 28. PAK1: A Therapeutic Target for Cancer Treatment.
ACS Med Chem Lett 2013; 4 (5): 431-2
*24900689* 24900689 PMC4027528 29. Combination Therapy: JAK PI3K/mTOR. A Novel Approach for Cancer Treatment.
ACS Med Chem Lett 2013; 4 (5): 429-30
*24900688* 24900688 PMC4027516 30. Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors.
ACS Med Chem Lett 2013; 4 (3): 358-62
*24900673* 24900673 PMC4027439 31. Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction.
ACS Med Chem Lett 2013; 4 (3): 353-7
*24900672* 24900672 PMC4027567 32. Deuterated clopidogrel analogues as a new generation of antiplatelet agents.
ACS Med Chem Lett 2013; 4 (3): 349-52
*24900671* 24900671 PMC4027137 33. Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator.
ACS Med Chem Lett 2013; 4 (3): 333-7
*24900670* 24900670 PMC4027362 34. Promising in Vitro anti-Alzheimer Properties for a Ruthenium(III) Complex.
ACS Med Chem Lett 2013; 4 (3): 329-32
*24900669* 24900669 PMC4027571 35. The structure of anthracycline derivatives determines their subcellular localization and cytotoxic activity.
ACS Med Chem Lett 2013; 4 (3): 323-8
*24900668* 24900668 PMC4027238 36. Inhibition of mTOR Kinase and Cancer Treatment.
ACS Med Chem Lett 2013; 4 (3): 321-2
*24900667* 24900667 PMC4027490 37. Identification of New Nonsteroidal RORalpha Ligands; Related Structure-Activity Relationships and Docking Studies.
ACS Med Chem Lett 2013; 4 (6): 504-8
*24900700* 24900700 PMC4027241 38. Negative allosteric modulators of metabotropic glutamate receptor subtype.
ACS Med Chem Lett 2013; 4 (6): 500-1
*24900698* 24900698 PMC4027404 39. Imidazopyrazine Derivatives As Inhibitors of mTOR.
ACS Med Chem Lett 2013; 4 (6): 498-9
*24900697* 24900697 PMC3686309 40. Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase.
ACS Med Chem Lett 2013; 4 (6): 542-546
*23795241* 23795241 PMC4027549 41. Rapid Determination of Ionization Constants (pK a) by UV Spectroscopy Using 96-Well Microtiter Plates.
ACS Med Chem Lett 2013; 4 (1): 142-5
*24900577* 24900577 PMC4027506 42. Biological evaluation of new largazole analogues: alteration of macrocyclic scaffold with click chemistry.
ACS Med Chem Lett 2013; 4 (1): 132-6
*24900575* 24900575 PMC4027153 43. Visible Light Controlled Release of Anticancer Drug through Double Activation of Prodrug.
ACS Med Chem Lett 2013; 4 (1): 124-7
*24900573* 24900573 PMC4027441 44. Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes.
ACS Med Chem Lett 2013; 4 (1): 118-23
*24900572* 24900572 PMC4027466 45. Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349.
ACS Med Chem Lett 2013; 4 (1): 103-7
*24900569* 24900569 PMC4027523 46. Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design.
ACS Med Chem Lett 2013; 4 (1): 91-7
*24900568* 24900568 PMC4027423 47. Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor.
ACS Med Chem Lett 2013; 4 (1): 85-90
*24900567* 24900567 PMC4027432 48. Tuning RNA Interference by Enhancing siRNA/PAZ Recognition.
ACS Med Chem Lett 2013; 4 (1): 75-8
*24900566* 24900566 PMC4027566 49. Novel 2-aminobenzamides as potential orally active antithrombotic agents.
ACS Med Chem Lett 2013; 4 (1): 32-6
*24900559* 24900559 PMC4027522 50. Insulin-like growth factor-1 receptor inhibitors: a potential cancer treatment: patent highlight.
ACS Med Chem Lett 2013; 4 (1): 20-1
*24900558* 24900558 PMC4027450 51. Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders: Patent Highlight.
ACS Med Chem Lett 2013; 4 (1): 18-9
*24900557* 24900557 PMC4030798 52. Treatment of Obesity and Related Disorders with Acetyl-CoA Carboxylase Inhibitors.
ACS Med Chem Lett 2013; 4 (1): 16-7
*24900556* 24900556 PMC4027151 53. Modulators of mitochondrial protein import.
ACS Med Chem Lett 2013; 4 (1): 14
*24900554* 24900554 PMC4030795 54. Multifunctional radical quenchers for the treatment of mitochondrial dysfunction.
ACS Med Chem Lett 2013; 4 (1): 12-3
*24900553* 24900553 PMC4027517 55. Modulators of the GPR119 Receptor for the Treatment of Metabolic Syndrome.
ACS Med Chem Lett 2013; 4 (1): 8-9
*24900551* 24900551 PMC4027553 56. Using medicinal chemistry to solve an old medical mystery.
ACS Med Chem Lett 2013; 4 (1): 2-4
*24900548* 24900548 PMC4027448 57. High-Throughput Selectivity Assays for Small-Molecule Inhibitors of beta-Catenin/T-Cell Factor Protein-Protein Interactions.
ACS Med Chem Lett 2013; 4 (2): 306-11
*24900664* 24900664 PMC4027476 58. Immune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses.
ACS Med Chem Lett 2013; 4 (2): 302-5
*24900663* 24900663 PMC4027554 59. Discovery of Indenopyrazoles as a New Class of Hypoxia Inducible Factor (HIF)-1 Inhibitors.
ACS Med Chem Lett 2013; 4 (2): 297-301
*24900662* 24900662 PMC4027501 60. Optimization of a Novel Series of TRPV4 Antagonists with In Vivo Activity in a Model of Pulmonary Edema.
ACS Med Chem Lett 2013; 4 (2): 293-6
*24900661* 24900661 PMC4027485 61. Probing the binding site of abl tyrosine kinase using in situ click chemistry.
ACS Med Chem Lett 2013; 4 (2): 274-7
*24900659* 24900659 PMC4027509 62. Discovery of a highly potent, orally active mitosis/angiogenesis inhibitor r1530 for the treatment of solid tumors.
ACS Med Chem Lett 2013; 4 (2): 259-63
*24900658* 24900658 PMC4027443 63. Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.
ACS Med Chem Lett 2013; 4 (2): 249-53
*24900657* 24900657 PMC4027513 64. Irreversible inhibitors of cysteine proteases.
ACS Med Chem Lett 2013; 4 (2): 163-4
*24900651* 24900651 PMC4027515 65. TRPV4 Antagonists: Potential Treatment for Congestive Heart Failure, Bladder Dysfunctions, and Pain.
ACS Med Chem Lett 2013; 4 (2): 159-60
*24900649* 24900649 PMC4027129 66. Aldosterone synthase inhibitors: targeting chronic kidney disease and diabetic nephropathy.
ACS Med Chem Lett 2013; 4 (2): 157-8
*24900648* 24900648 PMC4027132 67. A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases.
ACS Med Chem Lett 2013; 4 (2): 225-9
*24900645* 24900645 PMC4027363 68. Synthesis of 8-hydroxyquinoline derivatives as novel antitumor agents.
ACS Med Chem Lett 2013; 4 (2): 170-4
*24900641* 24900641 PMC4027243 69. Modulation of TRPV1 Receptor for Treatment of Pain and Other Disorders.
ACS Med Chem Lett 2013; 4 (2): 155-6
*24900639* 24900639 PMC4027533 70. Toll-like receptor agonists for treatment of viral infections.
ACS Med Chem Lett 2013; 4 (2): 153-4
*24900638* 24900638 PMC4027518 71. Nanomaterials for (Nano)medicine.
ACS Med Chem Lett 2013; 4 (2): 147-9
*24900637* 24900637 PMC4027226 72. Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes.
ACS Med Chem Lett 2013; 4 (4): 414-8
*24900686* 24900686 PMC4027229 73. Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway.
ACS Med Chem Lett 2013; 4 (4): 408-13
*24900685* 24900685 PMC4027436 74. Orally active fumagillin analogues: transformations of a reactive warhead in the gastric environment.
ACS Med Chem Lett 2013; 4 (4): 381-6
*24900682* 24900682 PMC4027375 75. Cyclopropyl-Fused 1,3-Thiazepines as BACE1 and BACE2 Inhibitors.
ACS Med Chem Lett 2013; 4 (4): 379-80
*24900681* 24900681 PMC4027149 76. Selective Cyp11B1 Inhibitors for the Treatment of Cortisol Dependent Diseases.
ACS Med Chem Lett 2013; 4 (4): 377-8
*24900680* 24900680 PMC4027240 77. Aldosterone synthase inhibitors.
ACS Med Chem Lett 2013; 4 (4): 375-6
*24900679* 24900679 PMC4027576 78. Inhibition of notch pathway signaling: a one compound mission to treat cancer.
ACS Med Chem Lett 2013; 4 (4): 373-4
*24900678* 24900678 PMC4027464 79. Targeting CCR2 Receptor To Treat Inflammation Diseases and Disorders.
ACS Med Chem Lett 2013; 4 (4): 371-2
*24900677* 24900677 PMC4027475 80. Regenerative medicinal chemistry: the in situ control of stem cells.
ACS Med Chem Lett 2013; 4 (4): 365-8
*24900675* 24900675 PMC4025657 81. Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor.
ACS Med Chem Lett 2012; 3 (9): 754-8
*24900544* 24900544 PMC4025659 82. Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist.
ACS Med Chem Lett 2012; 3 (9): 726-30
*24900539* 24900539 PMC4025671 83. Kinetic profile of amyloid formation in the presence of an aromatic inhibitor by nuclear magnetic resonance.
ACS Med Chem Lett 2012; 3 (10): 856-9
*24900390* 24900390 PMC4025665 84. Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.
ACS Med Chem Lett 2012; 3 (10): 850-5
*24900389* 24900389 PMC4025647 85. Identification of the Significant Involvement and Mechanistic Role of CYP3A4/5 in Clopidogrel Bioactivation.
ACS Med Chem Lett 2012; 3 (10): 844-9
*24900388* 24900388 PMC4025875 86. Structure-activity relationships for side chain oxysterol agonists of the hedgehog signaling pathway.
ACS Med Chem Lett 2012; 3 (10): 828-33
*24900386* 24900386 PMC4025654 87. Discovery of 2-Alkyl-1-arylsulfonylprolinamides as 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors.
ACS Med Chem Lett 2012; 3 (10): 793-8
*24900382* 24900382 PMC4025858 88. Novel compounds for the treatment of neurodegenerative diseases: patent highlight.
ACS Med Chem Lett 2012; 3 (10): 788
*24900380* 24900380 PMC4025803 89. Imidazotriazinone compounds: patent highlight.
ACS Med Chem Lett 2012; 3 (10): 787
*24900379* 24900379 PMC4025783 90. Novel use of leflunomide and malononitrilamides: patent highlight.
ACS Med Chem Lett 2012; 3 (10): 785
*24900377* 24900377 PMC4025674 91. Factor D Inhibitors for the Treatment of AMD: Patent Highlight.
ACS Med Chem Lett 2012; 3 (10): 781-2
*24900375* 24900375 PMC4025667 92. Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.
ACS Med Chem Lett 2012; 3 (11): 936-41
*24900410* 24900410 PMC4025817 93. Synthesis and SAR Studies of Fused Oxadiazines as gamma-Secretase Modulators for Treatment of Alzheimer's Disease.
ACS Med Chem Lett 2012; 3 (11): 931-5
*24900409* 24900409 PMC4025663 94. Novel Quinolinones as Activators of AMP Activated Protein Kinase: Patent Highlight.
ACS Med Chem Lett 2012; 3 (11): 884-5
*24900402* 24900402 PMC4025640 95. Novel and selective inhibitors of histone deacetylase: patent highlight.
ACS Med Chem Lett 2012; 3 (11): 879-80
*24900399* 24900399 PMC4025763 96. Compounds and Their Use as BACE Inhibitors: Patent Highlight.
ACS Med Chem Lett 2012; 3 (11): 875-6
*24900397* 24900397 PMC4025755 97. 5-Amino-oxazepine and 5-Amino-thiazepine Compounds as beta-Secretase Antagonists and Methods of Use: Patent Highlight.
ACS Med Chem Lett 2012; 3 (11): 873-4
*24900396* 24900396 PMC4025857 98. BACE-Inhibitors: Potential Treatment of Alzheimer Disease, Dementia, and Related Neurodegenerative Diseases. C. Spiro-Heterocyclic Derivatives: Patent Highlight.
ACS Med Chem Lett 2012; 3 (11): 871-2
*24900395* 24900395 PMC4025781 99. BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (B): 3-Amino-4-fluoro-1H-isoindol Derivatives: Patent Highlight.
ACS Med Chem Lett 2012; 3 (11): 869-70
*24900394* 24900394 PMC4025837 100. BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (A): 5,6-Dihydroimidazo[1,2-a]pyrazin-8-yl-amine Derivatives: Patent Highlight.
ACS Med Chem Lett 2012; 3 (11): 867-8
*24900393* 24900393 PMC4025676 101. Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.
ACS Med Chem Lett 2012; 3 (12): 1091-6
*24900432* 24900432 PMC4025792 102. Synthesis and antiproliferative activities of ottelione a analogues.
ACS Med Chem Lett 2012; 3 (12): 1075-80
*24900431* 24900431 PMC4025838 103. Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.
ACS Med Chem Lett 2012; 3 (12): 1050-3
*24900427* 24900427 PMC4025666 104. SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.
ACS Med Chem Lett 2012; 3 (12): 1024-8
*24900424* 24900424 PMC4025793 105. Strain-Promoted Catalyst-Free Click Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging Probes.
ACS Med Chem Lett 2012; 3 (12): 1019-23
*24900423* 24900423 PMC4025831 106. Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family Kinases.
ACS Med Chem Lett 2012; 3 (12): 997-1002
*24900421* 24900421 PMC4025866 107. Peptides and Pseudopeptides as SIRT6 Deacetylation Inhibitors.
ACS Med Chem Lett 2012; 3 (12): 969-74
*24900419* 24900419 PMC4025871 108. Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.
ACS Med Chem Lett 2012; 3 (12): 959-64
*24900417* 24900417 PMC4025843 109. GPR119 Modulators for the Treatment of Diabetes, Obesity, and Related Diseases: Patent Highlight.
ACS Med Chem Lett 2012; 3 (12): 955-8
*24900416* 24900416 PMC4025738 110. Compositions and methods for the treatment of mitochondrial diseases: patent highlight.
ACS Med Chem Lett 2012; 3 (12): 954
*24900415* 24900415 PMC4025778 111. Pharmaceutical composition comprising indole compound for treatment of diseases associated with oxidative stress: patent highlight.
ACS Med Chem Lett 2012; 3 (12): 953
*24900414* 24900414 PMC4025638 112. Preparation of N-(Hetero)cyclyl Benzamides as Inhibitors of the Activity of Complex III of the Mitochondrial Electron Transport Chain: Patent Highlight.
ACS Med Chem Lett 2012; 3 (12): 951
*24900412* 24900412
PMC4025810 113. Fluorescent Human EP3 Receptor Antagonists.
ACS Med Chem Lett 2012; 3 (9): 774-9
*24900547* 24900547 PMC4025765 114. Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.
ACS Med Chem Lett 2012; 3 (9): 731-5
*24900540* 24900540 PMC4025833 115. Prostaglandin e2 synthase-1 inhibitors as potential treatment for osteoarthritis: patent highlight.
ACS Med Chem Lett 2012; 3 (9): 703-4
*24900537* 24900537 PMC4025631 116. Inhibitors of LRRK2 as Treatment for Parkinson's Disease: Patent Highlight.
ACS Med Chem Lett 2012; 3 (9): 701-2
*24900536* 24900536 PMC4025661 117. Hepatitis C virus protease inhibitors: patent highlight.
ACS Med Chem Lett 2012; 3 (9): 699-700
*24900535* 24900535 PMC4025821 118. Cyclopropyl-spiro-piperidines Useful as Sodium Channel Blockers: Patent Highlight.
ACS Med Chem Lett 2012; 3 (9): 697-8
*24900534* 24900534 PMC4025779 119. Bromodomains: are readers right for epigenetic therapy?
ACS Med Chem Lett 2012; 3 (9): 691-4
*24900532* 24900532 PMC4025743 120. RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists.
ACS Med Chem Lett 2012; 3 (5): 427-32
*24900488* 24900488 PMC4025819 121. Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.
ACS Med Chem Lett 2012; 3 (5): 367-72
*24900480* 24900480 PMC4025823 122. The america invents act-overview and implications: patent highlight.
ACS Med Chem Lett 2012; 3 (3): 174-6
*24900452* 24900452 PMC4025655 123. Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetes.
ACS Med Chem Lett 2012; 3 (3): 198-202
*24900450* 24900450 PMC4025764 124. BACE1 Inhibitor Peptides: Can an Infinitely Small k cat Value Turn the Substrate of an Enzyme into Its Inhibitor?
ACS Med Chem Lett 2012; 3 (3): 193-7
*24900449* 24900449 PMC4025728 125. The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.
ACS Med Chem Lett 2012; 3 (6): 484-9
*24900499* 24900499 PMC4025634 126. Drug repurposing and the medicinal chemist.
ACS Med Chem Lett 2012; 3 (6): 442-4
*24900492* 24900492 PMC4025808 127. A new era for hepatitis C-new diagnostics tools and new weapons.
ACS Med Chem Lett 2012; 3 (6): 440-1
*24900491* 24900491 PMC4025669 128. Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics.
ACS Med Chem Lett 2012; 3 (7): 602-6
*24900516* 24900516 PMC4025795 129. Design and synthesis of potent, selective inhibitors of matriptase.
ACS Med Chem Lett 2012; 3 (7): 530-4
*24900505* 24900505 PMC4025814 130. Cracking the code: the promise of epigenetics.
ACS Med Chem Lett 2012; 3 (7): 521-3
*24900503* 24900503 PMC4025730 131. Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core.
ACS Med Chem Lett 2012; 3 (1): 74-8
*24900374* 24900374 PMC4025820 132. Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia.
ACS Med Chem Lett 2012; 3 (1): 63-8
*24900372* 24900372 PMC4025873 133. (18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.
ACS Med Chem Lett 2012; 3 (1): 58-62
*24900371* 24900371 PMC4025872 134. Sphingolipid analogues inhibit development of malaria parasites.
ACS Med Chem Lett 2012; 3 (1): 43-7
*24900369* 24900369 PMC4025658 135. Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
ACS Med Chem Lett 2012; 3 (2): 165-9
*24900447* 24900447 PMC4025800 136. Heteroaromatic Moieties in the Sphingosine Backbone of alpha-Galactosylceramides for Noncovalent Interactions with CD1d.
ACS Med Chem Lett 2012; 3 (2): 151-4
*24900444* 24900444 PMC4025662 137. Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.
ACS Med Chem Lett 2012; 3 (2): 135-9
*24900437* 24900437 PMC4025788 138. Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.
ACS Med Chem Lett 2012; 3 (2): 106-11
*24900436* 24900436 PMC4025756 139. Creation of readily accessible and orally active analogue of cortistatin a.
ACS Med Chem Lett 2012; 3 (8): 673-7
*24900528* 24900528 PMC4025753 140. Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.
ACS Med Chem Lett 2012; 3 (8): 653-7
*24900526* 24900526 PMC4025785 141. Identification of Hydroxybenzoic Acids as Selective Lactate Receptor (GPR81) Agonists with Antilipolytic Effects.
ACS Med Chem Lett 2012; 3 (8): 637-9
*24900524* 24900524 PMC4025751 142. Fused heterocyclic compounds as ion channel modulators: patent highlight.
ACS Med Chem Lett 2012; 3 (8): 616-7
*24900521* 24900521 PMC4025829 143. Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators: patent highlight.
ACS Med Chem Lett 2012; 3 (8): 614-5
*24900520* 24900520 PMC4025849 144. Fatty Acid synthase inhibitors as possible treatment for cancer: patent highlight.
ACS Med Chem Lett 2012; 3 (8): 612-3
*24900519* 24900519 PMC4025770 145. Potassium channel modulators as possible treatment for pain: patent highlight.
ACS Med Chem Lett 2012; 3 (8): 608-9
*24900517* 24900517 PMC4025746 146. Missing fragments: detecting cooperative binding in fragment-based drug design.
ACS Med Chem Lett 2012; 3 (4): 322-6
*24900472* 24900472 PMC4025749 147. Discovery and Structural Modification of 1-Phenyl-3-(1-phenylethyl)urea Derivatives as Inhibitors of Complement.
ACS Med Chem Lett 2012; 3 (4): 317-21
*24900471* 24900471 PMC4025841 148. Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents.
ACS Med Chem Lett 2012; 3 (4): 313-6
*24900470* 24900470 PMC4025660 149. Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 Modulators.
ACS Med Chem Lett 2012; 3 (4): 273-7
*24900463* 24900463 PMC4018160 150. Synthetic N-alkylated iminosugars as new potential immunosuppressive agents.
ACS Med Chem Lett 2011; 2 (9): 682-6
*24900363* 24900363 PMC4017971 151. Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.
ACS Med Chem Lett 2011; 2 (10): 774-9
*24900266* 24900266 PMC4018143 152. Aryltriflates as a Neglected Moiety in Medicinal Chemistry: A Case Study from a Lead Optimization of CXCL8 Inhibitors.
ACS Med Chem Lett 2011; 2 (10): 768-73
*24900265* 24900265 PMC4018089 153. Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility.
ACS Med Chem Lett 2011; 2 (10): 747-51
*24900262* 24900262 PMC4018129 154. Exploiting Fluorescence Lifetime Plasticity in FLIM: Target Molecule Localization in Cells and Tissues.
ACS Med Chem Lett 2011; 2 (10): 724-8
*24900259* 24900259 PMC4018100 155. Type 1 phototherapeutic agents, part I: preparation and cancer cell viability studies of novel photolabile sulfenamides.
ACS Med Chem Lett 2011; 2 (11): 828-33
*24900271* 24900271 PMC4018091 156. Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 Diabetes.
ACS Med Chem Lett 2011; 2 (11): 824-7
*24900270* 24900270 PMC4018126 157. Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity.
ACS Med Chem Lett 2011; 2 (11): 809-13
*24900269* 24900269 PMC4018076 158. Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases.
ACS Med Chem Lett 2011; 2 (5): 402-6
*24900320* 24900320 PMC4017972 159. Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist.
ACS Med Chem Lett 2011; 2 (5): 368-72
*24900318* 24900318 PMC4018074 160. Discovery of AMG 853, a CRTH2 and DP Dual Antagonist.
ACS Med Chem Lett 2011; 2 (5): 326-30
*24900313* 24900313 PMC4018071 161. Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone.
ACS Med Chem Lett 2011; 2 (3): 238-42
*24900301* 24900301 PMC4018058 162. Thermodynamics of ligand binding and efficiency.
ACS Med Chem Lett 2011; 2 (6): 433-7
*24900326* 24900326 PMC4018141 163. The 3-Deoxy Analogue of alpha-GalCer: Disclosing the Role of the 4-Hydroxyl Group for CD1d-Mediated NKT Cell Activation.
ACS Med Chem Lett 2011; 2 (7): 544-8
*24900347* 24900347 PMC4018161 164. Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity.
ACS Med Chem Lett 2011; 2 (7): 494-7
*24900337* 24900337 PMC4018110 165. Synthesis and SAR of Thiazolylmethylphenyl Glucoside as Novel C-Aryl Glucoside SGLT2 Inhibitors.
ACS Med Chem Lett 2011; 2 (2): 182-7
*24900297* 24900297 PMC4017979 166. Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemia.
ACS Med Chem Lett 2011; 2 (2): 171-6
*24900295* 24900295 PMC4018108 167. Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1).
ACS Med Chem Lett 2011; 2 (2): 102-6
*24900287* 24900287 PMC4017978 168. Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS.
ACS Med Chem Lett 2011; 2 (2): 97-101
*24900286* 24900286 PMC4018152 169. Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.
ACS Med Chem Lett 2011; 2 (12): 919-23
*24900281* 24900281 PMC4018162 170. Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists.
ACS Med Chem Lett 2011; 2 (12): 890-5
*24900277* 24900277 PMC4017985 171. The myo-1,2-Diaminocyclitol Scaffold Defines Potent Glucocerebrosidase Activators and Promising Pharmacological Chaperones for Gaucher Disease.
ACS Med Chem Lett 2011; 2 (8): 614-9
*24900357* 24900357 PMC4018135 172. A Strategy for Suppressing Redox Stress within Mitochondria.
ACS Med Chem Lett 2011; 2 (8): 608-13
*24900356* 24900356 PMC4007909 173. Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.
ACS Med Chem Lett 2010; 1 (6): 290-4
*24900210* 24900210 PMC4007795 174. Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase.
ACS Med Chem Lett 2010; 1 (6): 286-9
*24900209* 24900209 PMC4007898 175. Expanded Utility of the beta-Glucuronide Linker: ADCs That Deliver Phenolic Cytotoxic Agents.
ACS Med Chem Lett 2010; 1 (6): 277-80
*24900208* 24900208 PMC4007965 176. Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria.
ACS Med Chem Lett 2010; 1 (6): 258-62
*24900205* 24900205 PMC4007961 177. From taxuspine x to structurally simplified taxanes with remarkable p-glycoprotein inhibitory activity.
ACS Med Chem Lett 2010; 1 (8): 416-21
*24900226* 24900226 PMC4007973 178. Identification of a New Series of STAT3 Inhibitors by Virtual Screening.
ACS Med Chem Lett 2010; 1 (8): 371-5
*24900220* 24900220 PMC4007911 179. Vorinostat-like molecules as structural, stereochemical, and pharmacological tools.
ACS Med Chem Lett 2010; 1 (2): 70-4
*24900179* 24900179 PMC4007689 180. Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist.
ACS Med Chem Lett 2010; 1 (3): 130-4
*24900187* 24900187 PMC4007833 181. Discovery of Potent and Selective Urea-Based ROCK Inhibitors and Their Effects on Intraocular Pressure in Rats.
ACS Med Chem Lett 2010; 1 (4): 175-9
*24900192* 24900192 PMC4007829 182. Drawing the PDB: Protein-Ligand Complexes in Two Dimensions.
ACS Med Chem Lett 2010; 1 (9): 540-5
*24900245* 24900245 PMC4007908 183. Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR.
ACS Med Chem Lett 2010; 1 (9): 510-5
*24900240* 24900240 PMC4007847 184. Design of a high fragment efficiency library by molecular graph theory.
ACS Med Chem Lett 2010; 1 (9): 499-503
*24900238* 24900238 PMC4007905 185. A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis.
ACS Med Chem Lett 2010; 1 (9): 478-82
*24900234* 24900234 PMC4007964 186. Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.
ACS Med Chem Lett 2010; 1 (9): 454-9
*24900231* 24900231 PMC4007832 187. Metabolism-guided design of short-acting calcium-sensing receptor antagonists.
ACS Med Chem Lett 2010; 1 (5): 219-23
*24900198* 24900198 PMC4007794 188. Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases.
ACS Med Chem Lett 2010; 1 (5): 204-8
*24900195* 24900195 PMC4007842 189. Allosteric IGF-1R Inhibitors.
ACS Med Chem Lett 2010; 1 (5): 199-203
*24900194* 24900194 PMC4007845 190. Fragment screening by surface plasmon resonance.
ACS Med Chem Lett 2010; 1 (1): 44-8
*24900174* 24900174 PMC4007793 191. Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.
ACS Med Chem Lett 2010; 1 (1): 39-43
*24900173* 24900173 PMC4007900 192. Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295.
ACS Med Chem Lett 2010; 1 (1): 30-4
*24900171* 24900171 PMC4007969 193. Synthesis and SAR of Benzisothiazole- and Indolizine-beta-d-glucopyranoside Inhibitors of SGLT2.
ACS Med Chem Lett 2010; 1 (1): 19-23
*24900169* 24900169 PMC4046802 194. Next-generation in situ hybridization chain reaction: higher gain, lower cost, greater durability.
ACS Nano 2014; 8 (5): 4284-94
*24712299* 24712299 PMC3700402 195. Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood.
ACS Nano 2013; 7 (6): 4733-45
*23688050* 23688050 PMC3732798 196. Three-dimensional hierarchical plasmonic nano-architecture enhanced surface-enhanced Raman scattering immunosensor for cancer biomarker detection in blood plasma.
ACS Nano 2013; 7 (6): 4967-76
*23659430* 23659430 PMC3758924 197. Tiny grains give huge gains: nanocrystal-based signal amplification for biomolecule detection.
ACS Nano 2013; 7 (6): 5142-50
*23659350* 23659350 PMC3718078 198. A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo.
ACS Nano 2013; 7 (6): 5376-84 yunxiahu@yic.ac.cn
*23647441* 23647441 PMC4040258 199. Multichange isothermal mutagenesis: a new strategy for multiple site-directed mutations in plasmid DNA.
ACS Synth Biol 2013; 2 (8): 473-7 lmitch24@jhmi.edu.
*23654272* 23654272 PMC3663208 200. Role of lipid in forming an infectious prion?
Acta Biochim Biophys Sin (Shanghai) 2013; 45 (6): 485-93 wang.797@osu.edu
*23583976* 23583976 PMC4045145 201. Crystallographic studies of gas sorption in metal-organic frameworks.
Acta Crystallogr B Struct Sci Cryst Eng Mater 2014; 70 (Pt 3): 404-22
*24892587* 24892587 PMC4051508 202. Structure solution of DNA-binding proteins and complexes with ARCIMBOLDO libraries.
Acta Crystallogr D Biol Crystallogr 2014; 70 (Pt 6): 1743-57
*24914984* 24914984 PMC4051506 203. Structural and functional characterization of human and murine C5a anaphylatoxins.
Acta Crystallogr D Biol Crystallogr 2014; 70 (Pt 6): 1704-17
*24914981* 24914981 PMC4051500 204. CrowdPhase: crowdsourcing the phase problem.
Acta Crystallogr D Biol Crystallogr 2014; 70 (Pt 6): 1538-48
*24914965* 24914965 PMC3663119 205. Resolution of structural heterogeneity in dynamic crystallography.
Acta Crystallogr D Biol Crystallogr 2013; 69 (Pt 6): 946-59 renz@uchicago.edu
*23695239* 23695239 PMC3370912 206. Cloning, purification, crystallization and preliminary X-ray studies of human alpha1-microglobulin.
Acta Crystallogr Sect F Struct Biol Cryst Commun 2012; 68 (Pt 6): 692-4
*22684072* 22684072 PMC4037362 207. Effects of erythritol on endothelial function in patients with type 2 diabetes mellitus: a pilot study.
Acta Diabetol 2014; 51 (3): 513-6
*24366423* 24366423 PMC4033567 208. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
Acta Neurol Scand 2014; 129 (1): 61-70
*24107267* 24107267 PMC4059966 209. A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors.
Acta Neuropathol 2014; 128 (1): 39-54 bluemcke@uk-erlangen.de.
*24858213* 24858213 PMC4059967 210. Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings.
Acta Neuropathol 2014; 128 (1): 81-98
*24803225* 24803225 PMC4059960 211. Cutaneous neuropathy in Parkinson's disease: a window into brain pathology.
Acta Neuropathol 2014; 128 (1): 99-109 Doppler_K@ukw.de.
*24788821* 24788821 PMC4045499 212. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
Acta Neuropathol 2013; 126 (3): 307-28 jkfink@umich.edu
*23897027* 23897027 PMC3941651 213. C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
Acta Neuropathol 2013; 125 (6): 829-40
*23677375* 23677375 PMC3663903 214. Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau.
Acta Neuropathol 2013; 125 (6): 879-89 sk3295@columbia.edu
*23543187* 23543187 PMC4048455 215. Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Acta Neuropathol Commun 2014; 2 (ä): 53 morganbp@cardiff.ac.uk.
*24887075* 24887075 PMC4035095 216. Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis.
Acta Neuropathol Commun 2014; 2 (ä): 52 christopher.robinson@saskatoonhealthregion.ca.
*24887055* 24887055 PMC4050984 217. In vivo imaging reveals sigmoidal growth kinetic of beta-amyloid plaques.
Acta Neuropathol Commun 2014; 2 (ä): 30 Jochen.Herms@med.uni-muenchen.de.
*24678659* 24678659 PMC4046661 218. MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.
Acta Neuropathol Commun 2014; 2 (ä): 22 gabriel.von.euler@ki.se.
*24533944* 24533944 PMC4035092 219. Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model.
Acta Neuropathol Commun 2014; 2 (ä): 49
*24886907* 24886907 PMC4046770 220. The type of Abeta-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid beta-peptide (APP48) transgenic mice.
Acta Neuropathol Commun 2013; 1 (ä): 77 Dietmar.Thal@uni-ulm.de.
*24252227* 24252227 PMC4046834 221. Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.
Acta Neuropathol Commun 2013; 1 (ä): 8 s.brandner@ucl.ac.uk.
*24252267* 24252267 PMC4046675 222. Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43.
Acta Neuropathol Commun 2013; 1 (ä): 33 g.halliday@neura.edu.au.
*24252630* 24252630 PMC4046681 223. Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies.
Acta Neuropathol Commun 2013; 1 (ä): 79 darius.ebrahimi-fakhari@med.uni-heidelberg.de.
*24314025* 24314025 PMC4046662 224. Myositis facilitates preclinical accumulation of pathological prion protein in muscle.
Acta Neuropathol Commun 2013; 1 (ä): 78 m.glatzel@uke.de.
*24299111* 24299111
PMC4046664 225. NG2 cells, a new trail for Alzheimer's disease mechanisms?
Acta Neuropathol Commun 2013; 1 (ä): 7 malin.wennstrom@med.lu.se.
*24252600* 24252600 PMC4046687 226. ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies.
Acta Neuropathol Commun 2013; 1 (ä): 11 g.halliday@neura.edu.au.
*24252509* 24252509 PMC3787831 227. Intraocular pressure changes during sexual activity.
Acta Ophthalmol 2013; 91 (4): e324-5
*23607581* 23607581 PMC4031257 228. Neoplasm seeding in biopsy tract of the musculoskeletal system. A systematic review.
Acta Ortop Bras 2014; 22 (2): 106-10
*24899866* 24899866 PMC4025594 229. Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures.
Acta Otolaryngol 2014; 134 (5): 448-54
*24702224* 24702224 PMC4069124 230. Ocular VEMPs indicate repositioning of otoconia to the utricle after successful liberatory maneuvers in benign paroxysmal positioning vertigo.
Acta Otolaryngol 2013; 133 (12): 1297-303
*24245699* 24245699 PMC3756285 231. Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model.
Acta Physiol (Oxf) 2013; 208 (2): 172-9 julia.gronros@ki.se
*23497275* 23497275 PMC4054936 232. Tonic regulation of vascular permeability.
Acta Physiol (Oxf) 2013; 207 (4): 628-49 fecurry@ucdavis.edu
*23374222* 23374222 PMC4062075 233. Environmental conditions in water storage drums and influences on Aedes aegypti in Trinidad, West Indies.
Acta Trop 2009; 112 (1): 59-66
*19539592* 19539592 PMC4069040 234. Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.
Adolesc Health Med Ther 2014; 5 (ä): 115-25
*24966711* 24966711 PMC4041180 235. Dermatologic conditions in teenage adolescents in Nigeria.
Adolesc Health Med Ther 2014; 5 (ä): 79-87
*24966708* 24966708 PMC4049139 236. Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.
Adolesc Psychiatry (Hilversum) 2013; 3 (2): 123-134
*24921061* 24921061 PMC4063090 237. The effect of Helicobacter pylori eradication on liver enzymes in patients referring with unexplained hypertransaminasemia.
Adv Biomed Res 2014; 3 (ä): 131
*24949302* 24949302 PMC4063114 238. Increased risk of diabetes with statin use: Reconsidering the use of high potency statins.
Adv Biomed Res 2014; 3 (ä): 128
*24949299* 24949299 PMC4063104 239. Association of urinary transforming growth factor-beta1 with the ureteropelvic junction obstruction.
Adv Biomed Res 2014; 3 (ä): 123
*24949294* 24949294 PMC4063117 240. Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: A randomized controlled trial.
Adv Biomed Res 2014; 3 (ä): 121
*24949292* 24949292 PMC4028306 241. Comparison between the behavior of different hydrophobic peptides allowing membrane anchoring of proteins.
Adv Colloid Interface Sci 2014; 207 (ä): 223-39 Christian.Salesse@fmed.ulaval.ca.
*24560216* 24560216 PMC4043517 242. Recent advances in molecular, multimodal and theranostic ultrasound imaging.
Adv Drug Deliv Rev 2014; 72 (ä): 15-27 fkiessling@ukaachen.de.;
*24316070* 24316070 PMC3701723 243. Statistical analysis of big data on pharmacogenomics.
Adv Drug Deliv Rev 2013; 65 (7): 987-1000 jqfan@princeton.edu
*23602905* 23602905 PMC3578149 244. Mechanism of oral tolerance induction to therapeutic proteins.
Adv Drug Deliv Rev 2013; 65 (6): 759-73 wangxiaomei@ufl.edu
*23123293* 23123293 PMC4043215 245. Hypoxia and regulation of cancer cell stemness.
Adv Exp Med Biol 2014; 772 (ä): 41-53 zhong.yun@yale.edu.
*24272353* 24272353 PMC4059209 246. Neuroanatomy of the kisspeptin signaling system in mammals: comparative and developmental aspects.
Adv Exp Med Biol 2013; 784 (ä): 27-62 mlehman@umc.edu
*23550001* 23550001 PMC4060607 247. The molecular basis of mechanosensory transduction.
Adv Exp Med Biol 2012; 739 (ä): 142-55
*22399400* 22399400 PMC4050497 248. The role of Adams in Notch signaling.
Adv Exp Med Biol 2012; 727 (ä): 15-36
*22399336* 22399336 PMC4049144 249. Mechanism of radiation carcinogenesis: role of the TGFBI gene and the inflammatory signaling cascade.
Adv Exp Med Biol 2011; 720 (ä): 163-70 tkh1@Columbia.edu
*21901626* 21901626 PMC3757134 250. Non-viral gene delivery via membrane-penetrating, mannose-targeting supramolecular self-assembled nanocomplexes.
Adv Mater 2013; 25 (22): 3063-70
*23417835* 23417835 PMC4053229 251. Evaluation of the Potential Nephroprotective and Antimicrobial Effect of Camellia sinensis Leaves versus Hibiscus sabdariffa (In Vivo and In Vitro Studies).
Adv Pharmacol Sci 2014; 2014 (ä): 389834
*24949007* 24949007 PMC4074542 252. Genetic variation and HIV-associated neurologic disease.
Adv Virus Res 2013; 87 (ä): 183-240
*23809924* 23809924 PMC4048970 253. Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds.
Adv Wound Care (New Rochelle) 2014; 3 (6): 419-427
*24940556* 24940556 PMC3676658 254. Transforming Growth Factor Beta Signaling in Cutaneous Wound Healing: Lessons Learned from Animal Studies.
Adv Wound Care (New Rochelle) 2013; 2 (5): 225-237
*24761336* 24761336 PMC4056498 255. Mean platelet volume in supraventricular tachyarrhythmia can be affected by many cardiovascular risk factors.
Afr Health Sci 2013; 13 (4): 1176-7
*24940350* 24940350 PMC4056509 256. Platelet volume evaluation in patients with sepsis: associated factors should be considered.
Afr Health Sci 2013; 13 (4): 1174-5
*24940349* 24940349 PMC4056491 257. Stray dog trade fuelled by dog meat consumption as a risk factor for rabies infection in Calabar, southern Nigeria.
Afr Health Sci 2013; 13 (4): 1170-3
*24940348* 24940348 PMC4056497 258. Enteroviruses as a possible cause of hypertension, dilated cardiomyopathy (DCM) and hypertensive heart failure (HHF) in South western Nigeria.
Afr Health Sci 2013; 13 (4): 1098-106
*24940338* 24940338 PMC4056483 259. Changes in platelet functional parameters and CD62 P expression in liver cirrhosis.
Afr Health Sci 2013; 13 (4): 1079-83
*24940335* 24940335 PMC4056493 260. Sexually transmitted infections and their diagnoses: Bapedi experience.
Afr Health Sci 2013; 13 (4): 1047-53
*24940331* 24940331 PMC4056494 261. Knowledge, attitudes & barriers to condom use among female sex workers and truck drivers in Uganda: a mixed-methods study.
Afr Health Sci 2013; 13 (4): 1027-33
*24940328* 24940328 PMC4056485 262. Stereotypes on Nodding syndrome: responses of health workers in the affected region of northern Uganda.
Afr Health Sci 2013; 13 (4): 986-91
*24940322* 24940322 PMC4056489 263. Decompensated cirrhosis-related admissions in a large urban hospital in Uganda: prevalence, clinical and laboratory features and implications for planning patient management.
Afr Health Sci 2013; 13 (4): 927-32
*24940314* 24940314 PMC4066459 264. Van der Woude syndrome: a review of 11 cases seen at the Lagos University Teaching Hospital.
Afr J Paediatr Surg 2014; 11 (1): 52-5
*24647295* 24647295 PMC4066456 265. An evaluation of surgical outcome of bilateral cleft lip surgery using a modified Millard's (Fork Flap) technique.
Afr J Paediatr Surg 2013; 10 (4): 307-10
*24469478* 24469478 PMC3636412 266. Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity.
Age (Dordr) 2013; 35 (3): 993-1005
*22569962* 22569962 PMC3636388 267. Blueberry consumption prevents loss of collagen in bone matrix and inhibits senescence pathways in osteoblastic cells.
Age (Dordr) 2013; 35 (3): 807-20
*22555620* 22555620 PMC3636408 268. Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations.
Age (Dordr) 2013; 35 (3): 777-92 jhatsu@gmail.com
*22544617* 22544617 PMC3636397 269. Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8).
Age (Dordr) 2013; 35 (3): 659-71
*22411259* 22411259 PMC3636394 270. Accumulated hippocampal formaldehyde induces age-dependent memory decline.
Age (Dordr) 2013; 35 (3): 583-96
*22382760* 22382760 PMC3636393 271. Exceptionally old mice are highly resistant to lipoxidation-derived molecular damage.
Age (Dordr) 2013; 35 (3): 621-35
*22367548* 22367548 PMC4066613 272. Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people.
Age Ageing 2014; 43 (4): 496-502
*24590568* 24590568 PMC3893046 273. Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease.
Ageing Res Rev 2013; 12 (3): 823-31
*23380151* 23380151 PMC4069261 274. GDF11/myostatin and aging.
Aging (Albany NY) 2014; 6 (5): 351-2
*24902527* 24902527 PMC4069267 275. Age-related changes in tissue macrophages precede cardiac functional impairment.
Aging (Albany NY) 2014; 6 (5): 399-413
*24861132* 24861132 PMC4069266 276. Target of rapamycin signalling mediates the lifespan-extending effects of dietary restriction by essential amino acid alteration.
Aging (Albany NY) 2014; 6 (5): 390-8
*24861087* 24861087 PMC4069262 277. Cell fusion induced senescence.
Aging (Albany NY) 2014; 6 (5): 353-4
*24859630* 24859630 PMC3655122 278. Balance between autophagic pathways preserves retinal homeostasis.
Aging Cell 2013; 12 (3): 478-88
*23521856* 23521856 PMC4072458 279. Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity.
Aging Cell 2013; 12 (3): 525-30
*23489470* 23489470 PMC4037312 280. Link between PI3K/AKT/PTEN Pathway and NOX Proteinin Diseases.
Aging Dis 2014; 5 (3): 203-11
*24900943* 24900943 PMC4061705 281. Clostridium difficile infection in older adults.
Aging health 2013; 9 (4): 403-414
*24955106* 24955106 PMC4046103 282. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.
AIDS 2013; 27 (9): 1433-41 adb@cphiv.dk
*23945504* 23945504 PMC3664126 283. Posttraumatic stress symptoms among adults caring for orphaned children in HIV-endemic South Africa.
AIDS Behav 2013; 17 (5): 1755-63 caroline_kuo@brown.edu
*23539187* 23539187 PMC3653373 284. Dynamics of HIV type 1 recombination following superinfection.
AIDS Res Hum Retroviruses 2013; 29 (6): 963-70 fransje.koning@phe.gov.uk
*23495713* 23495713 PMC3653394 285. Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.
AIDS Res Hum Retroviruses 2013; 29 (6): 907-18
*23316755* 23316755 PMC4043700 286. Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND).
AIDS Res Ther 2014; 11 (ä): 13
*24894206* 24894206 PMC4033421 287. Point-of-Care Tests for HIV, Related Coinfections, and Blood-Borne Infections.
AIDS Res Treat 2014; 2014 (ä): 625082
*24895531* 24895531 PMC3928241 288. Recovery of white matter tracts in regions of peritumoral FLAIR hyperintensity with use of restriction spectrum imaging.
AJNR Am J Neuroradiol 2013; 34 (6): 1157-63
*23275591* 23275591 PMC4067264 289. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
AJNR Am J Neuroradiol 2010; 31 (10): 1911-6
*20616179* 20616179 PMC4067052 290. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.
AJR Am J Roentgenol 2013; 201 (3): W460-70 schroederj@njhealth.org
*23971478* 23971478 PMC4048027 291. Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.
AJR Am J Roentgenol 2013; 200 (3): W283-90 skawamo1@jhmi.edu
*23436873* 23436873 PMC3819397 292. Impaired odor identification in children with histories of heavy prenatal alcohol exposure.
Alcohol 2013; 47 (4): 275-8
*23683527* 23683527 PMC3670687 293. The influence of fetal ethanol exposure on subsequent development of the cerebral cortex as revealed by magnetic resonance imaging.
Alcohol Clin Exp Res 2013; 37 (6): 924-32
*23442156* 23442156 PMC3661684 294. The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.
Alcohol Clin Exp Res 2013; 37 (6): 1008-15 LBakhireva@salud.unm.edu
*23421919* 23421919 PMC3628976 295. Where the individual meets the ecological: a study of parent drinking patterns, alcohol outlets, and child physical abuse.
Alcohol Clin Exp Res 2013; 37 (6): 993-1000 freisthler@publicaffairs.ucla.edu
*23316780* 23316780 PMC3620963 296. Childhood trauma exposure and alcohol dependence severity in adulthood: mediation by emotional abuse severity and neuroticism.
Alcohol Clin Exp Res 2013; 37 (6): 984-92 melanies@mail.nih.gov
*23278300* 23278300 PMC4069026 297. Environmental enrichment alters neurotrophin levels after fetal alcohol exposure in rats.
Alcohol Clin Exp Res 2008; 32 (10): 1741-51
*18652597* 18652597 PMC4074361 298. Comparisons of Korsakoff and non-Korsakoff alcoholics on neuropsychological tests of prefrontal brain functioning.
Alcohol Clin Exp Res 2004; 28 (4): 667-75 oscar@bu.edu
*15100620* 15100620 PMC4036715 299. MSARC: Multiple sequence alignment by residue clustering.
Algorithms Mol Biol 2014; 9 (ä): 12
*24735785* 24735785 PMC4046270 300. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.
Aliment Pharmacol Ther 2014; 39 (11): 1276-85
*24738701* 24738701 PMC3703786 301. A new method for determining gastric acid output using a wireless pH-sensing capsule.
Aliment Pharmacol Ther 2013; 37 (12): 1198-209
*23639004* 23639004 PMC4065369 302. Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patients.
Aliment Pharmacol Ther 2013; 38 (11-12): 1347-53
*24117797* 24117797 PMC4070654 303. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia.
Aliment Pharmacol Ther 2009; 29 (7): 765-73 mm.walker@imperial.ac.uk
*19183150* 19183150 PMC3693732 304. Role of plasmacytoid dendritic cell subsets in allergic asthma.
Allergy 2013; 68 (6): 695-701
*23662841* 23662841 PMC4057652 305. Epigenetic regulation of asthma and allergic disease.
Allergy Asthma Clin Immunol 2014; 10 (1): 27
*24932182* 24932182 PMC4055052 306. Modulation of beta-amyloid by a single dose of GSK933776 in patients with mild Alzheimer's disease: a phase I study.
Alzheimers Res Ther 2014; 6 (2): 19
*24716469* 24716469 PMC4055042 307. TMEM106B expression is reduced in Alzheimer's disease brains.
Alzheimers Res Ther 2014; 6 (2): 17
*24684749* 24684749 PMC4055000 308. Platelet-activating factor antagonists enhance intracellular degradation of amyloid-beta42 in neurons via regulation of cholesterol ester hydrolases.
Alzheimers Res Ther 2014; 6 (2): 15
*24625058* 24625058 PMC4056615 309. Adjusting the compass: new insights into the role of angiogenesis in Alzheimer's disease.
Alzheimers Res Ther 2013; 5 (6): 64
*24351529* 24351529 PMC3664840 310. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease.
Am Heart J 2013; 165 (6): 964-971.e1 carson@umdnj.edu
*23708168* 23708168 PMC4065405 311. SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation.
Am J Cancer Res 2014; 4 (3): 245-55
*24959379* 24959379 PMC4065402 312. Histone/protein deacetylase SIRT1 is an anticancer therapeutic target.
Am J Cancer Res 2014; 4 (3): 211-21
*24959376* 24959376 PMC4075033 313. Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study).
Am J Cardiol 2013; 111 (3): 305-11 emily.obrien@duke.edu
*23168284* 23168284 PMC4062871 314. Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study).
Am J Cardiol 2012; 109 (1): 95-9 jhermida@unav.es
*21962993* 21962993 PMC4060258 315. Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry).
Am J Cardiol 2009; 104 (1): 24-8 j.french@unsw.edu.au
*19576316* 19576316 PMC4070991 316. Cavitating lung lesion as a manifestation of inflammatory tumor (pseudotumor) of the lung: A case report and literature review.
Am J Case Rep 2014; 15 (ä): 258-65
*24971159* 24971159 PMC4043539 317. Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C.
Am J Case Rep 2014; 15 (ä): 235-8
*24900166* 24900166 PMC3913474 318. Optimal management of metastatic melanoma: current strategies and future directions.
Am J Clin Dermatol 2013; 14 (3): 179-94
*23677693* 23677693 PMC3652918 319. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy.
Am J Clin Nutr 2013; 97 (6): 1163-77 csaba.kovesdy@va.gov
*23636234* 23636234 PMC3593738 320. Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer.
Am J Clin Oncol 2014; 37 (2): 167-71
*23211220* 23211220 PMC3121923 321. Merkel cell carcinoma.
Am J Clin Oncol 2013; 36 (3): 299-309
*21422993* 21422993 PMC3662488 322. Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.
Am J Clin Pathol 2013; 139 (6): 771-9
*23690120* 23690120 PMC4042540 323. Predictive validity of the Braden scale for patients in intensive care units.
Am J Crit Care 2013; 22 (6): 514-20
*24186823* 24186823 PMC3664337 324. Urinary bisphenol A and obesity in U.S. children.
Am J Epidemiol 2013; 177 (11): 1263-70 rbhandari@hsc.wvu.edu
*23558351* 23558351 PMC4050523 325. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis.
Am J Gastroenterol 2014; 109 (6): 887-94
*24732867* 24732867 PMC4046950 326. Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.
Am J Gastroenterol 2013; 108 (10): 1576-83
*23857477* 23857477 PMC4067697 327. Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes.
Am J Gastroenterol 2013; 108 (11): 1766-74
*24060757* 24060757 PMC4059598 328. Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium.
Am J Gastroenterol 2013; 108 (1): 106-12 mlazare1@jhmi.edu
*23229423* 23229423 PMC3664517 329. Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and "pure" Alzheimer disease.
Am J Geriatr Psychiatry 2013; 21 (6): 509-19 gpeavy@ucsd.edu.
*23567425* 23567425 PMC3655116 330. Pharmacologic treatment of anxiety disorders in Parkinson disease.
Am J Geriatr Psychiatry 2013; 21 (6): 520-8 gponton1@jhmi.edu.
*23567419* 23567419 PMC3784668 331. Telomere length and elevated iron: the influence of phenotype and HFE genotype.
Am J Hematol 2013; 88 (6): 492-6 mainouag@musc.edu
*23512844* 23512844 PMC3971999 332. Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease.
Am J Hematol 2013; 88 (6): 463-71
*23456977* 23456977 PMC3853132 333. SAMS, a syndrome of short stature, auditory-canal atresia, mandibular hypoplasia, and skeletal abnormalities is a unique neurocristopathy caused by mutations in Goosecoid.
Am J Hum Genet 2013; 93 (6): 1135-42
*24290375* 24290375 PMC3853004 334. Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis.
Am J Hum Genet 2013; 93 (6): 1100-7
*24268661* 24268661 PMC3852928 335. Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy.
Am J Hum Genet 2013; 93 (6): 1108-17
*24268659* 24268659 PMC3853412 336. Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears.
Am J Hum Genet 2013; 93 (6): 1118-25 chris.gordon@inserm.fr.
*24268655* 24268655
PMC3852919 337. Estimation of SNP heritability from dense genotype data.
Am J Hum Genet 2013; 93 (6): 1151-5 hong.lee@uq.edu.au.
*24314550* 24314550 PMC3852925 338. Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia.
Am J Hum Genet 2013; 93 (6): 1126-34
*24290376* 24290376 PMC3852924 339. Morbid obesity resulting from inactivation of the ciliary protein CEP19 in humans and mice.
Am J Hum Genet 2013; 93 (6): 1061-71 adelsh@clalit.org.il.
*24268657* 24268657 PMC3852921 340. Genetic and epigenetic regulation of human lincRNA gene expression.
Am J Hum Genet 2013; 93 (6): 1015-26
*24268656* 24268656 PMC3852926 341. Loss-of-function mutations in TBC1D20 cause cataracts and male infertility in blind sterile mice and Warburg micro syndrome in humans.
Am J Hum Genet 2013; 93 (6): 1001-14
*24239381* 24239381 PMC3693479 342. Day/night variability in blood pressure: influence of posture and physical activity.
Am J Hypertens 2013; 26 (6): 822-8 cjmorris@rics.bwh.harvard.edu
*23535155* 23535155 PMC3657486 343. Alterations in diastolic function in masked hypertension: findings from the masked hypertension study.
Am J Hypertens 2013; 26 (6): 808-15
*23446956* 23446956 PMC3697069 344. Low-dose angiotensin II infusion restores vascular function in cerebral arteries of high salt-fed rats by increasing copper/zinc superoxide dimutase expression.
Am J Hypertens 2013; 26 (6): 739-47
*23443725* 23443725 PMC3697070 345. Sildenafil increases sympathetically mediated vascular tone in humans.
Am J Hypertens 2013; 26 (6): 762-9 jmdopp@pharmacy.wisc.edu
*23443723* 23443723 PMC4049136 346. The DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients.
Am J Kidney Dis 2014; 63 (5): 851-4 francesca.tentori@arborresearch.org.;
*24613057* 24613057 PMC4042404 347. Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.
Am J Kidney Dis 2014; 63 (3): 446-55 esther.meijer@umcg.nl.;
*24342522* 24342522 PMC4076108 348. Treatment of depression and poor mental health among patients receiving maintenance dialysis: are there options other than a pill or a couch?
Am J Kidney Dis 2013; 61 (5): 694-7
*23582252* 23582252 PMC3660426 349. Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium.
Am J Kidney Dis 2013; 61 (6): 889-98
*23474010* 23474010 PMC3660473 350. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis.
Am J Kidney Dis 2013; 61 (6): 966-74 jflythe@partners.org
*23474007* 23474007 PMC4010151 351. Beyond mammography: new frontiers in breast cancer screening.
Am J Med 2013; 126 (6): 472-9 jennifer.drukteinis@moffitt.org
*23561631* 23561631 PMC4065345 352. Silver-Russell syndrome due to paternal H19/IGF2 hypomethylation in a twin girl born after in vitro fertilization.
Am J Med Genet A 2013; 161A (10): 2652-5
*24038823* 24038823 PMC3664118 353. Interrater reliability of a phenotypic assessment tool for the ear morphology in microtia.
Am J Med Genet A 2013; 161A (6): 1264-72 daniela.luquetti@seattlechildrens.org
*23616389* 23616389 PMC4048012 354. Co-occurrence of Joubert syndrome and Jeune asphyxiating thoracic dystrophy.
Am J Med Genet A 2010; 152A (6): 1411-9
*20503315* 20503315 PMC4051786 355. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.
Am J Med Genet A 2010; 152A (1): 4-24 rauenk@peds.ucsf.edu
*20014119* 20014119 PMC4041627 356. The ontology of craniofacial development and malformation for translational craniofacial research.
Am J Med Genet C Semin Med Genet 2013; 163C (4): 232-45
*24124010* 24124010 PMC4052756 357. Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency.
Am J Med Genet C Semin Med Genet 2006; 142C (2): 113-20 fscaglia@bcm.tmc.edu
*16602094* 16602094 PMC3856432 358. Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis.
Am J Nephrol 2013; 38 (1): 12-8 allfried@iupui.edu
*23816975* 23816975 PMC4074502 359. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.
Am J Nucl Med Mol Imaging 2014; 4 (4): 365-84
*24982822* 24982822 PMC4074496 360. Cyclotron production of (68)Ga via the (68)Zn(p,n)(68)Ga reaction in aqueous solution.
Am J Nucl Med Mol Imaging 2014; 4 (4): 303-10
*24982816* 24982816 PMC4052216 361. Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia.
Am J Obstet Gynecol 2013; 209 (1): 44.e1-6 lkiprono@umc.edu.
*23545163* 23545163 PMC3718454 362. Why does the healthy cornea resist Pseudomonas aeruginosa infection?
Am J Ophthalmol 2013; 155 (6): 961-970.e2
*23601656* 23601656 PMC3668032 363. Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar.
Am J Pathol 2013; 182 (6): 2407-17
*23602833* 23602833 PMC3668031 364. Inflammatory cytokines associated with degenerative disc disease control aggrecanase-1 (ADAMTS-4) expression in nucleus pulposus cells through MAPK and NF-kappaB.
Am J Pathol 2013; 182 (6): 2310-21
*23602832* 23602832 PMC3668025 365. Pazopanib inhibits the activation of PDGFRbeta-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells.
Am J Pathol 2013; 182 (6): 2368-79 grilbrun@mail.nih.gov
*23583652* 23583652 PMC3668027 366. IFN-gamma mediates the antitumor effects of radiation therapy in a murine colon tumor.
Am J Pathol 2013; 182 (6): 2345-54 scott_gerber@urmc.rochester.edu
*23583648* 23583648 PMC3668028 367. Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer.
Am J Pathol 2013; 182 (6): 2028-36
*23583283* 23583283 PMC3668023 368. Lymphatic vessel memory stimulated by recurrent inflammation.
Am J Pathol 2013; 182 (6): 2418-28
*23578386* 23578386 PMC3668017 369. B7h (ICOS-L) maintains tolerance at the fetomaternal interface.
Am J Pathol 2013; 182 (6): 2204-13
*23578385* 23578385 PMC3668026 370. Androgen receptor roles in the development of benign prostate hyperplasia.
Am J Pathol 2013; 182 (6): 1942-9
*23570837* 23570837 PMC3668035 371. Type VIII collagen mediates vessel wall remodeling after arterial injury and fibrous cap formation in atherosclerosis.
Am J Pathol 2013; 182 (6): 2241-53
*23567639* 23567639 PMC3668034 372. alpha(1,3)-Fucosyltransferases FUT4 and FUT7 control murine susceptibility to thrombosis.
Am J Pathol 2013; 182 (6): 2082-93
*23562273* 23562273 PMC4064792 373. Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor.
Am J Physiol 1997; 273 (2 Pt 1): G545-52
*9277436* 9277436 PMC3680646 374. Angiotensin II activates NF-kappaB through AT1A receptor recruitment of beta-arrestin in cultured rat vascular smooth muscle cells.
Am J Physiol Cell Physiol 2013; 304 (12): C1176-86 morinelt@musc.edu
*23576578* 23576578 PMC3680647 375. Diversity of lipid mediators in human adipose tissue depots.
Am J Physiol Cell Physiol 2013; 304 (12): C1141-9 jclaria@clinic.ub.es
*23364264* 23364264 PMC3677176 376. CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis.
Am J Physiol Cell Physiol 2013; 304 (11): C1105-15
*23576575* 23576575 PMC3677175 377. Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro.
Am J Physiol Cell Physiol 2013; 304 (11): C1053-63 dash@hemoshear.com
*23485712* 23485712 PMC4042096 378. Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.
Am J Physiol Endocrinol Metab 2014; 306 (11): E1225-38 masakazu.shiota@Vanderbilt.edu.
*24714398* 24714398 PMC3680700 379. Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9.
Am J Physiol Endocrinol Metab 2013; 304 (12): E1365-78
*23632630* 23632630 PMC3680701 380. Alterations in glutamine metabolism and its conversion to citrulline in sepsis.
Am J Physiol Endocrinol Metab 2013; 304 (12): E1359-64
*23612995* 23612995 PMC4056742 381. COMP-angiopoietin-1 enhances skeletal muscle blood flow and insulin sensitivity in mice.
Am J Physiol Endocrinol Metab 2009; 297 (2): E402-9
*19491299* 19491299 PMC3680718 382. Glucose metabolism in the Belgrade rat, a model of iron-loading anemia.
Am J Physiol Gastrointest Liver Physiol 2013; 304 (12): G1095-102
*23599042* 23599042 PMC3680717 383. Glyoxalate reductase/hydroxypyruvate reductase interacts with the sodium-dependent vitamin C transporter-1 to regulate cellular vitamin C homeostasis.
Am J Physiol Gastrointest Liver Physiol 2013; 304 (12): G1079-86 vsubrama@uci.edu
*23599041* 23599041 PMC3680716 384. Pathogenic role of mast cells in experimental eosinophilic esophagitis.
Am J Physiol Gastrointest Liver Physiol 2013; 304 (12): G1087-94
*23599040* 23599040 PMC3680687 385. Specific food structures supress appetite through reduced gastric emptying rate.
Am J Physiol Gastrointest Liver Physiol 2013; 304 (11): G1038-43 alan.mackie@ifr.ac.uk
*23578786* 23578786 PMC3680683 386. Emerging neuropeptide targets in inflammation: NPY and VIP.
Am J Physiol Gastrointest Liver Physiol 2013; 304 (11): G949-57 bchandr@emory.edu
*23538492* 23538492 PMC3680772 387. Physiological cyclic strain promotes endothelial cell survival via the induction of heme oxygenase-1.
Am J Physiol Heart Circ Physiol 2013; 304 (12): H1634-43
*23604711* 23604711 PMC3680768 388. A low-carbohydrate/high-fat diet reduces blood pressure in spontaneously hypertensive rats without deleterious changes in insulin resistance.
Am J Physiol Heart Circ Physiol 2013; 304 (12): H1733-42
*23604708* 23604708 PMC3680775 389. Nitric oxide regulates vascular adaptive mitochondrial dynamics.
Am J Physiol Heart Circ Physiol 2013; 304 (12): H1624-33
*23585138* 23585138 PMC3680773 390. Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts.
Am J Physiol Heart Circ Physiol 2013; 304 (12): H1719-26
*23585135* 23585135 PMC3680751 391. Partial functional redundancy between Hoxa5 and Hoxb5 paralog genes during lung morphogenesis.
Am J Physiol Lung Cell Mol Physiol 2013; 304 (12): L817-30
*23585229* 23585229 PMC3680747 392. Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system.
Am J Physiol Lung Cell Mol Physiol 2013; 304 (12): L863-72 drittirsch@gmail.com
*23564505* 23564505 PMC3680759 393. Regulation of myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by adrenomedullin.
Am J Physiol Lung Cell Mol Physiol 2013; 304 (11): L757-64
*23585227* 23585227 PMC3680762 394. VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice.
Am J Physiol Lung Cell Mol Physiol 2013; 304 (11): L803-12
*23585226* 23585226 PMC3680761 395. Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis.
Am J Physiol Lung Cell Mol Physiol 2013; 304 (11): L709-21
*23564511* 23564511 PMC3680795 396. A role for tricellulin in the regulation of gill epithelium permeability.
Am J Physiol Regul Integr Comp Physiol 2013; 304 (12): R1139-48 dennisk@yorku.ca
*23594608* 23594608 PMC3680793 397. Role of pituitary in K+ homeostasis: impaired renal responses to altered K+ intake in hypophysectomized rats.
Am J Physiol Regul Integr Comp Physiol 2013; 304 (12): R1166-74
*23594607* 23594607 PMC3680792 398. Identification of hypothalamic neuron-derived neurotrophic factor as a novel factor modulating appetite.
Am J Physiol Regul Integr Comp Physiol 2013; 304 (12): R1085-95 mardibyerly@gmail.com
*23576617* 23576617 PMC3680755 399. Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.
Am J Physiol Regul Integr Comp Physiol 2013; 304 (11): R917-28
*23552499* 23552499 PMC3680677 400. betaENaC is required for whole cell mechanically gated currents in renal vascular smooth muscle cells.
Am J Physiol Renal Physiol 2013; 304 (12): F1428-37
*23552864* 23552864 PMC3680674 401. Movement of NH(3) through the human urea transporter B: a new gas channel.
Am J Physiol Renal Physiol 2013; 304 (12): F1447-57 rrg8@cwru.edu
*23552862* 23552862 PMC3680676 402. Identifying renal medullary neighborhoods--when do distances matter?
Am J Physiol Renal Physiol 2013; 304 (12): F1411-2
*23552859* 23552859 PMC3680689 403. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.
Am J Physiol Renal Physiol 2013; 304 (11): F1335-46
*23552863* 23552863 PMC3680688 404. C-reactive protein exacerbates renal ischemia-reperfusion injury.
Am J Physiol Renal Physiol 2013; 304 (11): F1358-65
*23535585* 23535585 PMC3680692 405. Nitric oxide reduces Cl(-) absorption in the mouse cortical collecting duct through an ENaC-dependent mechanism.
Am J Physiol Renal Physiol 2013; 304 (11): F1390-7
*23515718* 23515718 PMC3680690 406. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
Am J Physiol Renal Physiol 2013; 304 (11): F1375-89
*23486009* 23486009 PMC3680691 407. HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor.
Am J Physiol Renal Physiol 2013; 304 (11): F1347-57
*23467424* 23467424 PMC4068121 408. Renal sodium transporter/channel expression and sodium excretion in P2Y2 receptor knockout mice fed a high-NaCl diet with/without aldosterone infusion.
Am J Physiol Renal Physiol 2011; 300 (3): F657-68
*21190950* 21190950 PMC4068120 409. Increased renal ENaC subunits and sodium retention in rats with chronic heart failure.
Am J Physiol Renal Physiol 2011; 300 (3): F641-9 hzheng@unmc.edu
*21159737* 21159737 PMC4067119 410. Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II.
Am J Physiol Renal Physiol 2009; 296 (5): F1052-60
*19261744* 19261744 PMC4067120 411. Development of vascular renin expression in the kidney critically depends on the cyclic AMP pathway.
Am J Physiol Renal Physiol 2009; 296 (5): F1006-12
*19261741* 19261741 PMC4066973 412. Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.
Am J Physiol Renal Physiol 2009; 296 (3): F496-504
*19144695* 19144695 PMC4063508 413. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse.
Am J Physiol Renal Physiol 2009; 296 (2): F317-27
*19036847* 19036847 PMC4067249 414. Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype.
Am J Physiol Renal Physiol 2009; 297 (2): F489-98
*19458121* 19458121 PMC4063418 415. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury.
Am J Physiol Renal Physiol 2008; 295 (1): F315-21 Florian.toegel@gmail.com
*18480180* 18480180 PMC4055567 416. The neuroepigenetics of suicide.
Am J Psychiatry 2013; 170 (5): 462-5
*23632831* 23632831 PMC4067768 417. Maternal and fetal alternative complement pathway activation in early severe preeclampsia.
Am J Reprod Immunol 2014; 71 (1): 55-60
*24128411* 24128411 PMC3727871 418. Hedgehog signaling in neonatal and adult lung.
Am J Respir Cell Mol Biol 2013; 48 (6): 703-10
*23371063* 23371063 PMC3931109 419. Transforming growth factor-beta(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
Am J Respir Cell Mol Biol 2013; 49 (6): 1135-45
*23937428* 23937428 PMC3734612 420. Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells.
Am J Respir Crit Care Med 2013; 187 (12): 1349-59
*23590269* 23590269 PMC3734611 421. B cells produce CXCL13 in lymphoid neogenesis during chronic obstructive pulmonary disease. The new kid on the block?
Am J Respir Crit Care Med 2013; 187 (11): 1162-4
*23725611* 23725611 PMC4051141 422. Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.
Am J Surg Pathol 2014; 38 (4): 480-93
*24451278* 24451278 PMC3654011 423. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.
Am J Surg Pathol 2013; 37 (6): 853-9
*23598967* 23598967 PMC3654051 424. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
Am J Surg Pathol 2013; 37 (6): 816-26 elainejaffe@nih.gov
*23598959* 23598959 PMC4058309 425. Pulsed electromagnetic field improves cardiac function in response to myocardial infarction.
Am J Transl Res 2014; 6 (3): 281-90
*24936220* 24936220 PMC4058306 426. Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.
Am J Transl Res 2014; 6 (3): 236-47
*24936217* 24936217 PMC4058303 427. Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease.
Am J Transl Res 2014; 6 (3): 188-205
*24936214* 24936214 PMC4058302 428. In vivo optical imaging of cancer metastasis using multiphoton microscopy: a short review.
Am J Transl Res 2014; 6 (3): 179-87
*24936213* 24936213 PMC4058786 429. Kidneys at higher risk of discard: expanding the role of dual kidney transplantation.
Am J Transplant 2014; 14 (2): 404-15
*24472195* 24472195 PMC4042397 430. Evidence for a gene controlling the induction of transplantation tolerance.
Am J Transplant 2014; 14 (4): 952-9
*24592880* 24592880 PMC4046334 431. Perivascular stromal cells as a potential reservoir of human cytomegalovirus.
Am J Transplant 2014; 14 (4): 820-30
*24592822* 24592822 PMC4047986 432. Liver defatting: an alternative approach to enable steatotic liver transplantation.
Am J Transplant 2012; 12 (12): 3176-83
*23057797* 23057797 PMC3752826 433. Histopathological features of tungiasis in Peru.
Am J Trop Med Hyg 2013; 88 (6): 1212-6 vicente_maco@hotmail.com
*23478579* 23478579 PMC4048013 434. Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma.
Am J Vet Res 2013; 74 (4): 621-8
*23531071* 23531071 PMC4052672 435. Enzymatic synthesis of epothilone A glycosides.
AMB Express 2014; 4 (ä): 31
*24949266* 24949266 PMC4041611 436. S100P: a novel therapeutic target for cancer.
Amino Acids 2011; 41 (4): 893-9
*20509035* 20509035 PMC4061150 437. Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred.
Amyloid 2014; 21 (2): 110-2
*24601799* 24601799 PMC4021035 438. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration.
Amyloid 2014; 21 (2): 71-5
*24446896* 24446896 PMC4056709 439. Incontinentia pigmenti or Bloch-Sulzberger syndrome: a rare X-linked genodermatosis.
An Bras Dermatol 2014; 89 (3): 486-9
*24937825* 24937825 PMC4056706 440. Variants of dermatofibroma--a histopathological study.
An Bras Dermatol 2014; 89 (3): 472-7
*24937822* 24937822 PMC4056705 441. Vitiligo--part 1.
An Bras Dermatol 2014; 89 (3): 461-70
*24937821* 24937821 PMC4056703 442. Herpes simplex virus: isolation, cytopathological characterization and antiviral sensitivity.
An Bras Dermatol 2014; 89 (3): 448-52
*24937819* 24937819 PMC4056699 443. Hepatitis C and hepatitis B virus infections in the etiopathogenesis of pemphigus.
An Bras Dermatol 2014; 89 (3): 423-6
*24937815* 24937815 PMC4056698 444. Factors that influence healing of chronic venous leg ulcers: a retrospective cohort.
An Bras Dermatol 2014; 89 (3): 414-22
*24937814* 24937814 PMC4056695 445. Leprosy: a review of laboratory and therapeutic aspects--part 2.
An Bras Dermatol 2014; 89 (3): 389-401
*24937811* 24937811 PMC4065382 446. Estimating glutathione synthesis with deuterated water: a model for peptide biosynthesis.
Anal Biochem 2008; 379 (1): 40-4
*18486587* 18486587 PMC3982967 447. Digital encoding of cellular mRNAs enabling precise and absolute gene expression measurement by single-molecule counting.
Anal Chem 2014; 86 (6): 2867-70
*24579851* 24579851 PMC4060246 448. Quantitation of cellular metabolic fluxes of methionine.
Anal Chem 2014; 86 (3): 1583-91
*24397525* 24397525
PMC3696186 449. Glycomic analysis using glycoprotein immobilization for glycan extraction.
Anal Chem 2013; 85 (11): 5555-61
*23688297* 23688297 PMC3988909 450. An on-chip, multichannel droplet sorter using standing surface acoustic waves.
Anal Chem 2013; 85 (11): 5468-74
*23647057* 23647057 PMC3674208 451. Multiplexed electrochemical protein detection and translation to personalized cancer diagnostics.
Anal Chem 2013; 85 (11): 5304-10 James.Rusling@uconn.edu
*23635325* 23635325 PMC3753689 452. Optimization of a Concanavalin A-based glucose sensor using fluorescence anisotropy.
Anal Chem 2013; 85 (11): 5397-404 bcummins@tamu.edu
*23627407* 23627407 PMC3712765 453. Microfluidic amperometric sensor for analysis of nitric oxide in whole blood.
Anal Chem 2013; 85 (12): 6066-72
*23692300* 23692300 PMC3713787 454. Using glycinylation, a chemical derivatization technique, for the quantitation of ubiquitinated proteins.
Anal Chem 2013; 85 (12): 5827-34 kstampe2@live.johnshopkins.edu
*23682733* 23682733 PMC3704224 455. Measurement of protein tyrosine phosphatase activity in single cells by capillary electrophoresis.
Anal Chem 2013; 85 (12): 6136-42
*23682679* 23682679 PMC3760192 456. Oriented covalent immobilization of antibodies for measurement of intermolecular binding forces between zipper-like contact surfaces of split inteins.
Anal Chem 2013; 85 (12): 6080-8
*23679912* 23679912 PMC3696989 457. Western blotting using microchip electrophoresis interfaced to a protein capture membrane.
Anal Chem 2013; 85 (12): 6073-9
*23672369* 23672369 PMC3692395 458. Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures.
Anal Chem 2013; 85 (12): 5666-75
*23662732* 23662732 PMC3725598 459. An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides.
Anal Chem 2013; 85 (12): 5787-95
*23659663* 23659663 PMC3691076 460. Discovery of undefined protein cross-linking chemistry: a comprehensive methodology utilizing 18O-labeling and mass spectrometry.
Anal Chem 2013; 85 (12): 5900-8
*23634697* 23634697 PMC4069200 461. In situ electrokinetic enhancement for self-assembled-monolayer-based electrochemical biosensing.
Anal Chem 2012; 84 (6): 2702-7
*22397486* 22397486 PMC4042682 462. Aptamer-functionalized microgel particles for protein detection.
Anal Chem 2011; 83 (23): 9138-45
*22017663* 22017663 PMC4074412 463. Karyometry of nuclear phenotypes in cutaneous squamous cell cancer.
Anal Quant Cytol Histol 2012; 34 (1): 1-8
*22590813* 22590813 PMC4061044 464. Progression of skin lesions from normal skin to squamous cell carcinoma.
Anal Quant Cytol Histol 2009; 31 (1): 17-25
*19320189* 19320189 PMC3734961 465. Integration of microsphere resonators with bioassay fluidics for whispering gallery mode imaging.
Analyst 2013; 138 (11): 3189-95
*23615457* 23615457 PMC3648618 466. The chemical origin of enhanced signals from tip-enhanced Raman detection of functionalized nanoparticles.
Analyst 2013; 138 (11): 3150-7
*23423552* 23423552 PMC4046509 467. Transitions in cell organization and in expression of contractile and extracellular matrix proteins during development of chicken aortic smooth muscle: evidence for a complex spatial and temporal differentiation program.
Anat Embryol (Berl) 1998; 197 (6): 421-37 reuveni@u.washington.edu
*9682974* 9682974 PMC4065365 468. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-the-art 2013.
Andrology 2014; 2 (1): 5-19
*24357628* 24357628 PMC4041737 469. Nitric Oxide Synthase is Necessary for Normal Urogenital Development.
Andrology (Los Angel) 2013; 2 (ä): 108
*24900949* 24900949 PMC4018690 470. The anatomical distribution of trigeminal neuralgia: a perspective and future directions.
Anesth Pain Med 2012; 1 (3): 212-3
*24904801* 24904801 PMC4018699 471. Tracheal intubation without use of muscle relaxants: comparison of remifentanil and alfentanil.
Anesth Pain Med 2012; 1 (3): 210-1
*24904800* 24904800 PMC4018697 472. Trigeminal neuralgia: a condition to be better understood.
Anesth Pain Med 2012; 1 (3): 201-2
*24904796* 24904796 PMC4018688 473. Pain management after surgery: a brief review.
Anesth Pain Med 2012; 1 (3): 184-6
*24904790* 24904790 PMC4018707 474. Remifentanil or alfentanil for endotracheal intubation.
Anesth Pain Med 2012; 1 (4): 277-8
*24904819* 24904819 PMC4018716 475. Post-dural puncture headache.
Anesth Pain Med 2012; 1 (4): 273-4
*24904817* 24904817 PMC4018712 476. Trigeminal pain and its distribution in different trigeminal nerve branches.
Anesth Pain Med 2012; 1 (4): 271-2
*24904816* 24904816 PMC4018713 477. Endotracheal intubation without neuromuscular blocking agents: is it a good and safe option?
Anesth Pain Med 2012; 1 (4): 267-8
*24904814* 24904814 PMC4018714 478. Commentary on: Use of Remifentanil and Alfentanil in Endotracheal Intubation: A Comparative Study.
Anesth Pain Med 2012; 1 (4): 265-6
*24904813* 24904813 PMC4018705 479. Use of oxycodone in pain management.
Anesth Pain Med 2012; 1 (4): 262-4
*24904812* 24904812 PMC4018717 480. Pulsed radiofrequency treatment for trigeminal neuralgia.
Anesth Pain Med 2012; 1 (4): 257-61
*24904811* 24904811 PMC3891459 481. Drug allergies and implications for dental practice.
Anesth Prog 2013; 60 (4): 188-97
*24423421* 24423421 PMC3891458 482. Three newly approved analgesics: an update.
Anesth Prog 2013; 60 (4): 178-87
*24423420* 24423420 PMC3891457 483. A comparison of fospropofol to midazolam for moderate sedation during outpatient dental procedures.
Anesth Prog 2013; 60 (4): 162-77
*24423419* 24423419 PMC3891456 484. Risk factors with intravenous sedation for patients with disabilities.
Anesth Prog 2013; 60 (4): 153-61
*24423418* 24423418 PMC4056591 485. AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.
Anesthesiology 2012; 116 (6): 1267-77 talmage.egan@hsc.utah.edu
*22531340* 22531340 PMC4065343 486. Selective reduction of barbituric acids using SmI2/H2O: synthesis, reactivity, and structural analysis of tetrahedral adducts.
Angew Chem Int Ed Engl 2013; 52 (48): 12559-63 michal.szostak@manchester.ac.uk.
*24123558* 24123558 PMC4031317 487. The structural basis of G-protein-coupled receptor signaling (Nobel Lecture).
Angew Chem Int Ed Engl 2013; 52 (25): 6380-8
*23650120* 23650120 PMC3800742 488. Chain-shattering polymeric therapeutics with on-demand drug-release capability.
Angew Chem Int Ed Engl 2013; 52 (25): 6435-9
*23650111* 23650111 PMC3892897 489. Rapidly reversible manipulation of molecular activity with dual chemical dimerizers.
Angew Chem Int Ed Engl 2013; 52 (25): 6450-4 ylin54@jhmi.edu
*23649661* 23649661 PMC3848500 490. Expressed protein ligation at methionine: N-terminal attachment of homocysteine, ligation, and masking.
Angew Chem Int Ed Engl 2013; 52 (24): 6210-3
*23629972* 23629972 PMC4070387 491. Heterologous expression and manipulation of three tetracycline biosynthetic pathways.
Angew Chem Int Ed Engl 2012; 51 (44): 11136-40
*23024027* 23024027 PMC4040390 492. Photochromic blockers of voltage-gated potassium channels.
Angew Chem Int Ed Engl 2009; 48 (48): 9097-101
*19882609* 19882609 PMC4061466 493. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.
Angiogenesis 2014; 17 (3): 471-94
*24482243* 24482243 PMC4061467 494. Sprouting and intussusceptive angiogenesis in postpneumonectomy lung growth: mechanisms of alveolar neovascularization.
Angiogenesis 2014; 17 (3): 541-51
*24150281* 24150281 PMC4006695 495. Neuronal sirtuin1 mediates retinal vascular regeneration in oxygen-induced ischemic retinopathy.
Angiogenesis 2013; 16 (4): 985-92 jing.chen@childrens.harvard.edu.
*23912262* 23912262 PMC4059510 496. Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.
Angiogenesis 2012; 15 (3): 469-80
*22562363* 22562363 PMC3960905 497. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.
Ann Am Thorac Soc 2013; 10 (3): 179-87
*23802813* 23802813 PMC3960969 498. Nasal nitric oxide is an important test in the diagnostic pathway for primary ciliary dyskinesia.
Ann Am Thorac Soc 2013; 10 (6): 645-7
*24364768* 24364768 PMC3960989 499. How variability in clinical phenotypes should guide research into disease mechanisms in asthma.
Ann Am Thorac Soc 2013; 10 Suppl (ä): S109-17
*24313760* 24313760 PMC3960967 500. Large ABCA3 and SFTPC deletions resulting in lung disease.
Ann Am Thorac Soc 2013; 10 (6): 602-7
*24024739* 24024739 PMC3662513 501. Long-term temporal variation in the organization of an ant-plant network.
Ann Bot 2013; 111 (6): 1285-93
*23704116* 23704116 PMC3662527 502. The diversity, ecology and evolution of extrafloral nectaries: current perspectives and future challenges.
Ann Bot 2013; 111 (6): 1243-50 marazzibrigitte@gmail.com
*23704115* 23704115 PMC3662523 503. Non-additive benefit or cost? Disentangling the indirect effects that occur when plants bearing extrafloral nectaries and honeydew-producing insects share exotic ant mutualists.
Ann Bot 2013; 111 (6): 1295-307 amy_savage@ncsu.edu
*23609021* 23609021 PMC3662517 504. A review of the allozyme data set for the Canarian endemic flora: causes of the high genetic diversity levels and implications for conservation.
Ann Bot 2013; 111 (6): 1059-73
*23609020* 23609020 PMC3662522 505. A pollinators' eye view of a shelter mimicry system.
Ann Bot 2013; 111 (6): 1155-65 nicolas.vereecken@ulb.ac.be
*23599249* 23599249 PMC3662525 506. 'Hemiepiphyte': a confusing term and its history.
Ann Bot 2013; 111 (6): 1015-20 gerhard.zotz@uni-oldenburg.de
*23589630* 23589630 PMC3662512 507. Jasmonates: biosynthesis, perception, signal transduction and action in plant stress response, growth and development. An update to the 2007 review in Annals of Botany.
Ann Bot 2013; 111 (6): 1021-58 cwastern@ipb-halle.de
*23558912* 23558912 PMC3662507 508. Complete tylosis formation in a latest Permian conifer stem.
Ann Bot 2013; 111 (6): 1075-81
*23532049* 23532049 PMC3662506 509. Diversity and evolution of a trait mediating ant-plant interactions: insights from extrafloral nectaries in Senna (Leguminosae).
Ann Bot 2013; 111 (6): 1263-75 marazzibrigitte@gmail.com
*23104672* 23104672 PMC3662505 510. The phylogenetic distribution of extrafloral nectaries in plants.
Ann Bot 2013; 111 (6): 1251-61 mgw58@cornell.edu
*23087129* 23087129 PMC4052420 511. Type B aortic dissection.
Ann Cardiothorac Surg 2014; 3 (3): 339
*24967178* 24967178 PMC4052421 512. Spinal cord protection and related complications in endovascular management of B dissection: LSA revascularization and CSF drainage.
Ann Cardiothorac Surg 2014; 3 (3): 336-8
*24967177* 24967177 PMC4052407 513. Hybrid arch repair in chronic B dissection.
Ann Cardiothorac Surg 2014; 3 (3): 333-5
*24967176* 24967176 PMC4052417 514. Optimization of distal landing zone for TEVAR in chronic dissection.
Ann Cardiothorac Surg 2014; 3 (3): 329-32
*24967175* 24967175 PMC4052416 515. Open repair in chronic type B dissection with connective tissue disorders.
Ann Cardiothorac Surg 2014; 3 (3): 325-8
*24967174* 24967174 PMC4052411 516. Emergent treatment of aortic rupture in acute type B dissection.
Ann Cardiothorac Surg 2014; 3 (3): 319-24
*24967173* 24967173 PMC4052422 517. Usefulness of new imaging methods for assessment of type B aortic dissection.
Ann Cardiothorac Surg 2014; 3 (3): 314-8
*24967172* 24967172 PMC4052415 518. Endovascular management of chronic post-dissection aneurysms.
Ann Cardiothorac Surg 2014; 3 (3): 307-13
*24967171* 24967171 PMC4052412 519. Importance of dynamic aortic evaluation in planning TEVAR.
Ann Cardiothorac Surg 2014; 3 (3): 300-6
*24967170* 24967170 PMC4052414 520. Best surgical option for arch extension of type B dissection: the endovascular approach.
Ann Cardiothorac Surg 2014; 3 (3): 292-9
*24967169* 24967169 PMC4052419 521. Predicting aortic enlargement in type B aortic dissection.
Ann Cardiothorac Surg 2014; 3 (3): 285-91
*24967168* 24967168 PMC4052413 522. Incidence, risk factors, outcome and projected future burden of acute aortic dissection.
Ann Cardiothorac Surg 2014; 3 (3): 278-84
*24967167* 24967167 PMC4052418 523. Partial thrombosis of the false lumen influences aortic growth in type B dissection.
Ann Cardiothorac Surg 2014; 3 (3): 275-7
*24967166* 24967166 PMC4052409 524. Current management and outcome of chronic type B aortic dissection: results with open and endovascular repair since the advent of thoracic endografting.
Ann Cardiothorac Surg 2014; 3 (3): 264-74
*24967165* 24967165 PMC4052404 525. Predictors of false lumen thrombosis in type B aortic dissection treated with TEVAR.
Ann Cardiothorac Surg 2014; 3 (3): 255-63
*24967164* 24967164 PMC4052410 526. Natural history of Type B aortic dissection: ten tips.
Ann Cardiothorac Surg 2014; 3 (3): 247-54
*24967163* 24967163 PMC4052408 527. Management of complicated and uncomplicated acute type B dissection. A systematic review and meta-analysis.
Ann Cardiothorac Surg 2014; 3 (3): 234-46
*24967162* 24967162 PMC4052406 528. Systematic review of outcomes of combined proximal stent-grafting with distal bare stenting for management of aortic dissection.
Ann Cardiothorac Surg 2014; 3 (3): 223-33
*24967161* 24967161 PMC4052566 529. Double sleeve uniportal video-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Ann Cardiothorac Surg 2014; 3 (2): E2
*24967160* 24967160 PMC4069668 530. Comparative study of syphilid and syphilid-like eruptions on the palms.
Ann Dermatol 2014; 26 (3): 426-8
*24966657* 24966657 PMC4069665 531. Small cell melanoma.
Ann Dermatol 2014; 26 (3): 419-21
*24966654* 24966654 PMC4069661 532. Neutrophilic dermatosis confined to the lymphedematous area.
Ann Dermatol 2014; 26 (3): 411-3
*24966650* 24966650 PMC4069660 533. Updated diagnosis criteria for confluent and reticulated papillomatosis: a case report.
Ann Dermatol 2014; 26 (3): 409-10
*24966649* 24966649 PMC4069652 534. Two Clinically Unusual Cases of Folliculotropic Mycosis Fungoides: One with and the Other without Syringotropism.
Ann Dermatol 2014; 26 (3): 385-91
*24966641* 24966641 PMC4069644 535. Identification of dermatophytes by polymerase chain reaction-restriction fragment length polymorphism analysis of metalloproteinase-1.
Ann Dermatol 2014; 26 (3): 338-42
*24966633* 24966633 PMC4069643 536. Notch intracellular domain expression in various skin fibroproliferative diseases.
Ann Dermatol 2014; 26 (3): 332-7
*24966632* 24966632 PMC4069639 537. Elevated serum levels of visfatin in patients with henoch-schonlein purpura.
Ann Dermatol 2014; 26 (3): 303-7
*24966628* 24966628 PMC4069638 538. Calcitriol May Down-Regulate mRNA Over-Expression of Toll-Like Receptor-2 and -4, LL-37 and Proinflammatory Cytokines in Cultured Human Keratinocytes.
Ann Dermatol 2014; 26 (3): 296-302
*24966627* 24966627 PMC3660511 539. Sleep duration and all-cause mortality: a critical review of measurement and associations.
Ann Epidemiol 2013; 23 (6): 361-70 lkurina@health.bsd.uchicago.edu
*23622956* 23622956 PMC4073016 540. Endoscopic submucosal dissection: experience in an Australian tertiary center.
Ann Gastroenterol 2014; 27 (3): 212-218
*24976337* 24976337 PMC4073015 541. Hepatobiliary tuberculosis.
Ann Gastroenterol 2014; 27 (3): 207-211
*24976240* 24976240 PMC4073014 542. Main ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndrome.
Ann Gastroenterol 2014; 27 (3): 200-206
*24976114* 24976114 PMC4073033 543. "Concomitant" or "sequential" eradication of Helicobacter pylori: which regimen comes first?
Ann Gastroenterol 2014; 27 (3): 280-281
*24976082* 24976082 PMC4073013 544. Application of confocal laser endomicroscopy in the diagnosis and management of Barrett's esophagus.
Ann Gastroenterol 2014; 27 (3): 193-199
*24976007* 24976007 PMC4073012 545. The morphologic evolution of necrotic pancreatic fluid collections and their management. Asymptomatic: delay, defer and don't panic!
Ann Gastroenterol 2014; 27 (3): 191-192
*24975900* 24975900 PMC4073023 546. Morphological features of fluid collections on endoscopic ultrasound in acute necrotizing pancreatitis: do they change over time?
Ann Gastroenterol 2014; 27 (3): 258-261
*24975052* 24975052 PMC4073020 547. Insulin resistance in euglycemic cirrhosis.
Ann Gastroenterol 2014; 27 (3): 237-243
*24974878* 24974878 PMC4073038 548. Helicobacter pylori infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension.
Ann Gastroenterol 2014; 27 (3): 285
*24974838* 24974838 PMC4073018 549. Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence?
Ann Gastroenterol 2014; 27 (3): 224-230
*24974805* 24974805 PMC4052826 550. An analysis of early developmental trauma in social anxiety disorder and posttraumatic stress disorder.
Ann Gen Psychiatry 2014; 13 (ä): 16
*24920955* 24920955 PMC4050292 551. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).
Ann Hematol 2014; 93 (7): 1083-95 olaf.penack@charite.de.
*24777705* 24777705 PMC4026117 552. Daily sedative interruption versus intermittent sedation in mechanically ventilated critically ill patients: a randomized trial.
Ann Intensive Care 2014; 4 (ä): 14
*24900938* 24900938 PMC4071749 553. Uncommon locations and presentations of hydatid cyst.
Ann Med Health Sci Res 2014; 4 (3): 447-52
*24971224* 24971224 PMC4071743 554. Factors Associated with Symptomatic Vulvovaginal Candidiasis: A Study among Women Attending a Primary Healthcare Clinic in Kwazulu-Natal, South Africa.
Ann Med Health Sci Res 2014; 4 (3): 410-6
*24971218* 24971218 PMC4071740 555. Cytomorphological patterns of tubercular lymphadenitis revisited.
Ann Med Health Sci Res 2014; 4 (3): 393-6
*24971215* 24971215 PMC4071726 556. Papaya extract to treat dengue: a novel therapeutic option?
Ann Med Health Sci Res 2014; 4 (3): 320-4
*24971201* 24971201 PMC4049420 557. What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health.
Ann N Y Acad Sci 2014; 1311 (ä): 14-30
*24650218* 24650218 PMC4063556 558. Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.
Ann N Y Acad Sci 2012; 1258 (ä): 149-58
*22731728* 22731728 PMC4041083 559. The clinical significance of drug craving.
Ann N Y Acad Sci 2012; 1248 (ä): 1-17 stiffany@buffalo.edu
*22172057* 22172057
PMC4070945 561. A knockout mouse resource for the biomedical research community.
Ann N Y Acad Sci 2011; 1245 (ä): 24-6 kclloyd@ucdavis.edu
*22211970* 22211970 PMC4063203 562. Probiotic therapy in radiation-induced intestinal injury and repair.
Ann N Y Acad Sci 2009; 1165 (ä): 190-4 mciorba@im.wustl.edu
*19538306* 19538306 PMC4071456 563. Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory.
Ann Neurol 2011; 69 (5): 819-30
*21472769* 21472769 PMC4034590 564. Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator.
Ann Noninvasive Electrocardiol 2014; 19 (3): 247-57
*24252154* 24252154 PMC4034593 565. Diagnostic accuracy of a new cardiac electrical biomarker for detection of electrocardiogram changes suggestive of acute myocardial ischemic injury.
Ann Noninvasive Electrocardiol 2014; 19 (2): 129-44
*24118724* 24118724 PMC4065577 566. The Relationship between the Occupational Exposure of Trichloroethylene and Kidney Cancer.
Ann Occup Environ Med 2014; 26 (ä): 12
*24955246* 24955246 PMC3979282 567. Rapid detection of transition metals in welding fumes using paper-based analytical devices.
Ann Occup Hyg 2014; 58 (4): 413-23
*24515892* 24515892 PMC3916742 568. Influence of analysis methods on interpretation of hazard maps.
Ann Occup Hyg 2013; 57 (5): 558-70 Kirsten.Koehler@ColoState.EDU
*23258453* 23258453 PMC4071753 569. A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy.
Ann Oncol 2014; 25 (7): 1333-9 richard.gralla@nbhn.net.;
*24631949* 24631949 PMC4071755 570. Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.
Ann Oncol 2014; 25 (7): 1340-6 paul.hesketh@lahey.org.;
*24608196* 24608196 PMC4071754 571. A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.
Ann Oncol 2014; 25 (7): 1328-33 maapro@genolier.net.;
*24603643* 24603643 PMC4047287 572. Penile cancer: current therapy and future directions.
Ann Oncol 2013; 24 (5): 1179-89
*23293117* 23293117 PMC3660083 573. Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.
Ann Oncol 2013; 24 (6): 1427-34 hpark2@bidmc.harvard.edu
*23508824* 23508824 PMC4049544 574. Glycogenic hepatopathy in a Korean girl with poorly controlled type 1 diabetes mellitus.
Ann Pediatr Endocrinol Metab 2014; 19 (1): 49-52
*24926465* 24926465 PMC4049552 575. A novel de novo mutation within PHEX gene in a young girl with hypophosphatemic rickets and review of literature.
Ann Pediatr Endocrinol Metab 2014; 19 (1): 36-41
*24926462* 24926462 PMC4049553 576. Iodine and thyroid function.
Ann Pediatr Endocrinol Metab 2014; 19 (1): 8-12
*24926457* 24926457 PMC4027071 577. Refractory rickets caused by mild distal renal tubular acidosis.
Ann Pediatr Endocrinol Metab 2013; 18 (3): 152-5
*24904870* 24904870 PMC4027076 578. Genotype-phenotype correlation in 27 pediatric patients in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a single center.
Ann Pediatr Endocrinol Metab 2013; 18 (3): 128-34
*24904866* 24904866 PMC4027072 579. Genetic syndromes associated with overgrowth in childhood.
Ann Pediatr Endocrinol Metab 2013; 18 (3): 101-5
*24904861* 24904861 PMC4027067 580. p.R182C mutation in Korean twin with congenital lipoid adrenal hyperplasia.
Ann Pediatr Endocrinol Metab 2013; 18 (1): 40-3
*24904850* 24904850 PMC4027064 581. Gitelman syndrome combined with complete growth hormone deficiency.
Ann Pediatr Endocrinol Metab 2013; 18 (1): 36-9
*24904849* 24904849 PMC4027063 582. Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves' disease.
Ann Pediatr Endocrinol Metab 2013; 18 (1): 32-5
*24904848* 24904848 PMC4027069 583. Different clinical courses of central precocious girls according to their age at presentation and treatment.
Ann Pediatr Endocrinol Metab 2013; 18 (1): 19-25
*24904846* 24904846 PMC4027066 584. Response to three years of growth hormone therapy in girls with Turner syndrome.
Ann Pediatr Endocrinol Metab 2013; 18 (1): 13-8
*24904845* 24904845 PMC4027062 585. Role of insulin-like growth factor binding protein-3 in glucose and lipid metabolism.
Ann Pediatr Endocrinol Metab 2013; 18 (1): 9-12
*24904844* 24904844 PMC4027091 586. Sex hormone binding globulin, free estradiol index, and lipid profiles in girls with precocious puberty.
Ann Pediatr Endocrinol Metab 2013; 18 (2): 81-4
*24904857* 24904857 PMC4027092 587. Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus.
Ann Pediatr Endocrinol Metab 2013; 18 (2): 65-70
*24904854* 24904854 PMC4027090 588. The pleiomorphic actions of vitamin D and its importance for children.
Ann Pediatr Endocrinol Metab 2013; 18 (2): 45-54
*24904851* 24904851 PMC4027086 589. Serum glycated albumin as a new glycemic marker in pediatric diabetes.
Ann Pediatr Endocrinol Metab 2013; 18 (4): 208-13
*24904879* 24904879 PMC4027080 590. Boys with precocious or early puberty: incidence of pathological brain magnetic resonance imaging findings and factors related to newly developed brain lesions.
Ann Pediatr Endocrinol Metab 2013; 18 (4): 183-90
*24904875* 24904875 PMC4027083 591. Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents.
Ann Pediatr Endocrinol Metab 2013; 18 (4): 161-7
*24904871* 24904871 PMC4033106 592. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.
Ann Rheum Dis 2014; 73 (6): 1020-6
*24595547* 24595547 PMC4033146 593. Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials.
Ann Rheum Dis 2014; 73 (6): 1000-6
*24553909* 24553909 PMC4033144 594. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.
Ann Rheum Dis 2014; 73 (6): 990-9
*24482301* 24482301 PMC4033122 595. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.
Ann Rheum Dis 2014; 73 (6): 1052-9
*23831963* 23831963 PMC4033120 596. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.
Ann Rheum Dis 2014; 73 (6): 1144-50
*23644670* 23644670 PMC3726193 597. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA).
Ann Rheum Dis 2013; 72 (6): 901-7
*22915618* 22915618 PMC3580123 598. Inhalation injury severity and systemic immune perturbations in burned adults.
Ann Surg 2013; 257 (6): 1137-46
*23160150* 23160150 PMC4062448 599. Peutz-Jeghers syndrome with germline mutation of STK11.
Ann Surg Treat Res 2014; 86 (6): 325-30
*24949325* 24949325 PMC4062446 600. Long-term results of laparoscopic splenectomy in pediatric chronic immune thrombocytopenic purpura.
Ann Surg Treat Res 2014; 86 (6): 314-8
*24949323* 24949323 PMC3718051 601. Completion pneumonectomy: outcomes for benign and malignant indications.
Ann Thorac Surg 2013; 95 (6): 1885-90; discussion 1890-1 puriv@wudosis.wustl.edu
*23647859* 23647859 PMC3745224 602. Cardioprotective mechanism of diazoxide involves the inhibition of succinate dehydrogenase.
Ann Thorac Surg 2013; 95 (6): 2042-50
*23642436* 23642436 PMC4041111 603. Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition.
Ann Thorac Surg 2008; 86 (4): 1286-92
*18805178* 18805178 PMC4066974 604. Hydrogen tunneling links protein dynamics to enzyme catalysis.
Annu Rev Biochem 2013; 82 (ä): 471-96 klinman@berkeley.edu
*23746260* 23746260 PMC4047973 605. Membrane fission reactions of the mammalian ESCRT pathway.
Annu Rev Biochem 2013; 82 (ä): 663-92
*23527693* 23527693 PMC4044913 606. Systemic amyloidoses.
Annu Rev Biochem 2013; 82 (ä): 745-74 Blancasmejia.luis@mayo.edu
*23451869* 23451869 PMC4041481 607. Considering protonation as a posttranslational modification regulating protein structure and function.
Annu Rev Biophys 2013; 42 (ä): 289-314
*23451893* 23451893 PMC4053175 608. Interactions between nuclei and the cytoskeleton are mediated by SUN-KASH nuclear-envelope bridges.
Annu Rev Cell Dev Biol 2010; 26 (ä): 421-44 dastarr@ucdavis.edu
*20507227* 20507227 PMC4070676 609. Regulation of APC/C activators in mitosis and meiosis.
Annu Rev Cell Dev Biol 2008; 24 (ä): 475-99
*18598214* 18598214 PMC4066667 610. Regulation of spermatogonial stem cell self-renewal in mammals.
Annu Rev Cell Dev Biol 2008; 24 (ä): 263-86 jmo15@psu.edu
*18588486* 18588486 PMC4040413 611. Feeding mechanisms of adult Lepidoptera: structure, function, and evolution of the mouthparts.
Annu Rev Entomol 2010; 55 (ä): 307-27 harald.krenn@univie.ac.at
*19961330* 19961330 PMC4040957 612. The power of meta-analysis in genome-wide association studies.
Annu Rev Genomics Hum Genet 2013; 14 (ä): 441-65 orestis.panagiotou@nih.gov.
*23724904* 23724904 PMC4067317 613. The inflammasome NLRs in immunity, inflammation, and associated diseases.
Annu Rev Immunol 2011; 29 (ä): 707-35 antigen@med.unc.edu
*21219188* 21219188 PMC4041162 614. Imaging of atherosclerosis.
Annu Rev Med 2011; 62 (ä): 25-40 d.owen@imperial.ac.uk
*21226610* 21226610 PMC4001765 615. Biological consequences and advantages of asymmetric bacterial growth.
Annu Rev Microbiol 2013; 67 (ä): 417-35 ybrun@indiana.edu.
*23808335* 23808335 PMC4049541 616. Mechanisms of gamma oscillations.
Annu Rev Neurosci 2012; 35 (ä): 203-25 Gyorgy.Buzsaki@nyumc.org
*22443509* 22443509 PMC4041712 617. Mechanisms of inflammatory responses in obese adipose tissue.
Annu Rev Nutr 2012; 32 (ä): 261-86
*22404118* 22404118 PMC4074518 618. Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.
Annu Rev Pharmacol Toxicol 2013; 53 (ä): 331-54 smontaner@umaryland.edu
*23092247* 23092247 PMC4041114 619. TRPA1: A gatekeeper for inflammation.
Annu Rev Physiol 2013; 75 (ä): 181-200 dbautista@berkeley.edu
*23020579* 23020579 PMC4052444 620. Thirty years and counting: finding meaning in the N400 component of the event-related brain potential (ERP).
Annu Rev Psychol 2011; 62 (ä): 621-47 mkutas@ucsd.edu
*20809790* 20809790 PMC4062304 621. Next Generation Statistical Genetics: Modeling, Penalization, and Optimization in High-Dimensional Data.
Annu Rev Stat Appl 2014; 1 (1): 279-300
*24955378* 24955378 PMC3837877 622. Megalin contributes to kidney accumulation and nephrotoxicity of colistin.
Antimicrob Agents Chemother 2013; 57 (12): 6319-24
*24100504* 24100504 PMC3837871 623. Whole-cell screening-based identification of inhibitors against the intraphagosomal survival of Mycobacterium tuberculosis.
Antimicrob Agents Chemother 2013; 57 (12): 6372-7
*24060878* 24060878 PMC3837866 624. Optimizing empiric antibiotic therapy in patients with severe beta-lactam allergy.
Antimicrob Agents Chemother 2013; 57 (12): 5918-23
*24041892* 24041892 PMC3837890 625. Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.
Antimicrob Agents Chemother 2013; 57 (12): 5820-9
*24018260* 24018260 PMC4038990 626. Tetrahydrobiopterin in cardiovascular health and disease.
Antioxid Redox Signal 2014; 20 (18): 3040-77
*24294830* 24294830 PMC4038991 627. Circadian redox and metabolic oscillations in mammalian systems.
Antioxid Redox Signal 2014; 20 (18): 2966-81
*24063592* 24063592 PMC4026403 628. The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.
Antioxid Redox Signal 2014; 20 (17): 2681-91
*24295151* 24295151 PMC4026401 629. Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation.
Antioxid Redox Signal 2014; 20 (17): 2667-80
*24206143* 24206143 PMC4026218 630. NADPH oxidases in vascular pathology.
Antioxid Redox Signal 2014; 20 (17): 2794-814
*24180474* 24180474 PMC4026213 631. The branched-chain aminotransferase proteins: novel redox chaperones for protein disulfide isomerase--implications in Alzheimer's disease.
Antioxid Redox Signal 2014; 20 (16): 2497-513
*24094038* 24094038 PMC3638555 632. Redox reactions of hemoglobin: mechanisms of toxicity and control.
Antioxid Redox Signal 2013; 18 (17): 2251-3
*23330885* 23330885 PMC4047995 633. Molecular controls of the oxygenation and redox reactions of hemoglobin.
Antioxid Redox Signal 2013; 18 (17): 2298-313 bona@duke.edu
*23198874* 23198874 PMC3638515 634. Redox reactions of myoglobin.
Antioxid Redox Signal 2013; 18 (17): 2342-51 mprichards@ansci.wisc.edu
*22900975* 22900975 PMC3638564 635. CD163 and inflammation: biological, diagnostic, and therapeutic aspects.
Antioxid Redox Signal 2013; 18 (17): 2352-63
*22900885* 22900885 PMC3638512 636. Protective role of methionine sulfoxide reductase A against ischemia/reperfusion injury in mouse kidney and its involvement in the regulation of trans-sulfuration pathway.
Antioxid Redox Signal 2013; 18 (17): 2241-50
*22657153* 22657153 PMC4070859 637. The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis.
Appl Clin Genet 2014; 7 (ä): 105-15
*24971029* 24971029 PMC3837797 638. Bacteriophage orphan DNA methyltransferases: insights from their bacterial origin, function, and occurrence.
Appl Environ Microbiol 2013; 79 (24): 7547-55
*24123737* 24123737 PMC3837830 639. Analysis of magnetosome chains in magnetotactic bacteria by magnetic measurements and automated image analysis of electron micrographs.
Appl Environ Microbiol 2013; 79 (24): 7755-62
*24096429* 24096429 PMC3837754 640. Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes.
Appl Environ Microbiol 2013; 79 (23): 7390-7
*24056460* 24056460 PMC3837753 641. Aerobic biofilms grown from Athabasca watershed sediments are inhibited by increasing concentrations of bituminous compounds.
Appl Environ Microbiol 2013; 79 (23): 7398-412
*24056457* 24056457 PMC3837759 642. Bacterial persister cell formation and dormancy.
Appl Environ Microbiol 2013; 79 (23): 7116-21
*24038684* 24038684 PMC4047484 643. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production.
Appl Microbiol Biotechnol 2014; 98 (12): 5301-17
*24743983* 24743983 PMC3689753 644. Enhanced fluorescence emission using a photonic crystal coupled to an optical cavity.
Appl Phys Lett 2013; 102 (22): 221114
*23825806* 23825806 PMC3664132 645. Clinical applications of Gallium-68.
Appl Radiat Isot 2013; 76 (ä): 2-13
*23522791* 23522791 PMC4062565 646. Efficient conversion of solar energy to biomass and electricity.
Aquat Biosyst 2014; 10 (ä): 4
*24976951* 24976951 PMC4049508 647. Interactions of marine mammals and birds with offshore membrane enclosures for growing algae (OMEGA).
Aquat Biosyst 2014; 10 (ä): 3
*24955238* 24955238 PMC4063437 648. Auxin biosynthesis.
Arabidopsis Book 2014; 12 (ä): e0173 yundezhao@ucsd.edu.
*24955076* 24955076 PMC4042058 649. Diabetes insipidus as a main symptom of cancer.
Arch Med Sci 2014; 10 (2): 401-5
*24904679* 24904679 PMC4042035 650. A glimpse into the early origins of medieval anatomy through the oldest conserved human dissection (Western Europe, 13(th) c. A.D.).
Arch Med Sci 2014; 10 (2): 366-73
*24904674* 24904674 PMC4042052 651. Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial.
Arch Med Sci 2014; 10 (2): 309-14
*24904666* 24904666 PMC4042047 652. Abdominal aortic aneurysm repair: long-term follow-up of endovascular versus open repair.
Arch Med Sci 2014; 10 (2): 273-82
*24904660* 24904660 PMC4042041 653. Second- versus first-generation drug-eluting stents for diabetic patients: a meta-analysis.
Arch Med Sci 2014; 10 (2): 213-21
*24904652* 24904652 PMC3664836 654. Anhedonia: a concept analysis.
Arch Psychiatr Nurs 2013; 27 (3): 121-9 nancy_ho@med.unc.edu
*23706888* 23706888 PMC3669655 655. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae.
Arch Virol 2013; 158 (6): 1425-32
*23358612* 23358612 PMC4066373 656. "Megavirales", a proposed new order for eukaryotic nucleocytoplasmic large DNA viruses.
Arch Virol 2013; 158 (12): 2517-21
*23812617* 23812617 PMC4051450 657. Prevalence of cardiovascular risk factors in hemodialysis patients - The CORDIAL study.
Arq Bras Cardiol 2014; 102 (5): 473-80
*24759948* 24759948 PMC4062364 658. Relationship between anthropometric measures and cardiovascular risk factors in children and adolescents.
Arq Bras Cardiol 2013; 101 (4): 288-96
*23979777* 23979777 PMC4059045 659. Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study.
Arterioscler Thromb Vasc Biol 2014; 34 (1): 231-6
*24177327* 24177327 PMC3745999 660. Phenotypic polarization of macrophages in atherosclerosis.
Arterioscler Thromb Vasc Biol 2013; 33 (6): 1120-6 nl2q@virginia.edu
*23640492* 23640492 PMC3758923 661. Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cells.
Arterioscler Thromb Vasc Biol 2013; 33 (6): 1350-9
*23559633* 23559633 PMC3844532 662. mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells.
Arterioscler Thromb Vasc Biol 2013; 33 (6): 1212-20
*23559629* 23559629 PMC3739701 663. Cocaine and specific cocaine metabolites induce von Willebrand factor release from endothelial cells in a tissue-specific manner.
Arterioscler Thromb Vasc Biol 2013; 33 (6): 1230-7
*23539221* 23539221 PMC3898631 664. Conversion of human fibroblasts to functional endothelial cells by defined factors.
Arterioscler Thromb Vasc Biol 2013; 33 (6): 1366-75
*23520160* 23520160 PMC4054973 665. Fibroblast-like synoviocytes induce calcium mineral formation and deposition.
Arthritis 2014; 2014 (ä): 812678
*24963403* 24963403 PMC4034491 666. Treatment of nongout joint deposition diseases: an update.
Arthritis 2014; 2014 (ä): 375202
*24895535* 24895535 PMC4062926 667. Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritis.
Arthritis Res Ther 2014; 16 (3): R109
*24886659* 24886659 PMC4060209 668. PEG-ing down (and preventing?) the cause of pegloticase failure.
Arthritis Res Ther 2014; 16 (3): 112
*25142440* 25142440 PMC4060450 669. Resequencing the susceptibility gene, ITGAM, identifies two functionally deleterious rare variants in systemic lupus erythematosus cases.
Arthritis Res Ther 2014; 16 (3): R114
*24886912* 24886912 PMC4060543 670. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1beta-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
Arthritis Res Ther 2014; 16 (3): R113
*24886859* 24886859 PMC4060195 671. Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology.
Arthritis Res Ther 2014; 16 (3): R111
*24886750* 24886750 PMC4060257 672. CD4(+)CD25(-)Foxp3(+) T cells: a marker for lupus nephritis?
Arthritis Res Ther 2014; 16 (2): R104
*24774748* 24774748
PMC4060204 673. T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
Arthritis Res Ther 2014; 16 (2): R62
*24598455* 24598455 PMC4060440 674. Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.
Arthritis Res Ther 2014; 16 (2): R60
*24588936* 24588936 PMC4060570 675. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study.
Arthritis Res Ther 2014; 16 (2): R79
*24661633* 24661633 PMC4060173 676. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Arthritis Res Ther 2014; 16 (2): R77
*24655341* 24655341 PMC4060463 677. Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis.
Arthritis Res Ther 2014; 16 (2): R68
*24620998* 24620998 PMC4060228 678. CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction.
Arthritis Res Ther 2014; 16 (1): R52
*24517500* 24517500 PMC4060485 679. Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome.
Arthritis Res Ther 2014; 16 (2): R89
*24713464* 24713464 PMC4060196 680. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
Arthritis Res Ther 2014; 16 (2): R86
*24708674* 24708674 PMC4060546 681. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
Arthritis Res Ther 2014; 16 (2): R101
*24758294* 24758294 PMC4060464 682. Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent.
Arthritis Res Ther 2014; 16 (2): R98
*24745366* 24745366 PMC4060547 683. Interleukin-10 attenuation of collagen-induced arthritis is associated with suppression of interleukin-17 and retinoid-related orphan receptor gammat production in macrophages and repression of classically activated macrophages.
Arthritis Res Ther 2014; 16 (2): R96
*24742125* 24742125 PMC4061723 684. NLRP3 promotes autophagy of urate crystals phagocytized by human osteoblasts.
Arthritis Res Ther 2013; 15 (6): R176
*24456929* 24456929 PMC3978450 685. Serological identification of fast progressors of structural damage with rheumatoid arthritis.
Arthritis Res Ther 2013; 15 (4): R86
*23945134* 23945134 PMC3979153 686. Animal models of fibromyalgia.
Arthritis Res Ther 2013; 15 (6): 222
*24314231* 24314231 PMC4060544 687. Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA).
Arthritis Res Ther 2013; 15 (3): R70
*23799890* 23799890 PMC4060542 688. Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells.
Arthritis Res Ther 2013; 15 (3): 215
*23796020* 23796020 PMC4060240 689. What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
Arthritis Res Ther 2013; 15 (3): 213
*23731900* 23731900 PMC4060242 690. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.
Arthritis Res Ther 2013; 15 (3): R65
*23721694* 23721694 PMC4060562 691. Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens.
Arthritis Res Ther 2013; 15 (3): R64
*23718630* 23718630 PMC4060381 692. Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers.
Arthritis Res Ther 2013; 15 (3): R63
*23718566* 23718566 PMC4060252 693. Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism.
Arthritis Res Ther 2013; 15 (3): R58
*23663495* 23663495 PMC4061722 694. Psoriatic arthritis: recent progress in pathophysiology and drug development.
Arthritis Res Ther 2013; 15 (6): 224
*24611179* 24611179 PMC4060361 695. Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus.
Arthritis Res Ther 2012; 14 (3): R110 SebastianEickenberg@web.de
*22571761* 22571761 PMC4060356 696. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.
Arthritis Res Ther 2012; 14 (2): R46 johanna.gustafsson@karolinska.se
*22390680* 22390680 PMC4033527 697. Brief report: deficient thymic output in rheumatoid arthritis despite abundance of prethymic progenitors.
Arthritis Rheum 2013; 65 (10): 2567-72
*23818218* 23818218 PMC3672311 698. Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.
Arthritis Rheum 2013; 65 (6): 1592-602
*23508371* 23508371 PMC4066615 699. Protein kinase cdelta deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.
Arthritis Rheum 2013; 65 (8): 2161-71
*23666743* 23666743 PMC4074430 700. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.
Arthritis Rheum 2012; 64 (1): 285-96 schan001@mc.duke.edu
*22031171* 22031171 PMC4074307 701. Distribution and alteration of lymphatic vessels in knee joints of normal and osteoarthritic mice.
Arthritis Rheumatol 2014; 66 (3): 657-66
*24574226* 24574226 PMC4034588 702. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis.
Arthritis Rheumatol 2014; 66 (3): 513-22
*24574210* 24574210 PMC4044505 703. Matrix-associated chondroplasty: a novel platelet-rich plasma and concentrated nucleated bone marrow cell-enhanced cartilage restoration technique.
Arthrosc Tech 2014; 3 (2): e279-82
*24904777* 24904777 PMC4044512 704. Ultrasound-assisted hip arthroscopy.
Arthrosc Tech 2014; 3 (2): e255-9
*24904772* 24904772 PMC4040007 705. Basic knee arthroscopy part 4: chondroplasty, meniscectomy, and cruciate ligament evaluation.
Arthrosc Tech 2013; 2 (4): e507-8
*24892018* 24892018 PMC4040015 706. Basic knee arthroscopy part 3: diagnostic arthroscopy.
Arthrosc Tech 2013; 2 (4): e503-5
*24892017* 24892017 PMC4040009 707. Basic knee arthroscopy part 2: surface anatomy and portal placement.
Arthrosc Tech 2013; 2 (4): e501-2
*24892016* 24892016 PMC4040008 708. Basic knee arthroscopy part 1: patient positioning.
Arthrosc Tech 2013; 2 (4): e497-9
*24892015* 24892015 PMC4070077 709. An extensive analysis of disease-gene associations using network integration and fast kernel-based gene prioritization methods.
Artif Intell Med 2014; 61 (2): 63-78 valentini@di.unimi.it.;
*24726035* 24726035 PMC4070079 710. Identifying significant edges in graphical models of molecular networks.
Artif Intell Med 2013; 57 (3): 207-17 m.scutari@ucl.ac.uk
*23395009* 23395009 PMC4038860 711. Keyhole concept in cerebral aneurysm clipping and tumor removal by the supraciliary lateral supraorbital approach.
Asian J Neurosurg 2014; 9 (1): 14-20
*24891885* 24891885 PMC3691774 712. Perchlorate radiolysis on Mars and the origin of martian soil reactivity.
Astrobiology 2013; 13 (6): 515-20 Richard.C.Quinn@nasa.gov
*23746165* 23746165 PMC3664268 713. Letting a typical mouse judge whether mouse social interactions are atypical.
Autism Res 2013; 6 (3): 212-20
*23436806* 23436806 PMC4058525 714. Coeliac disease.
Autoimmune Dis 2014; 2014 (ä): 623784
*24982802* 24982802 PMC4055614 715. Role of autoimmune responses in periodontal disease.
Autoimmune Dis 2014; 2014 (ä): 596824
*24963400* 24963400 PMC4036413 716. Autoimmunity and the gut.
Autoimmune Dis 2014; 2014 (ä): 152428
*24900918* 24900918 PMC4034124 717. Metabolic control of the epigenome in systemic Lupus erythematosus.
Autoimmunity 2014; 47 (4): 256-64
*24128087* 24128087 PMC4034120 718. DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.
Autoimmunity 2014; 47 (4): 265-71
*24117194* 24117194 PMC4046632 719. Pathogenic mechanisms in systemic lupus erythematosus.
Autoimmunity 2010; 43 (1): 1-6
*20014960* 20014960 PMC3672305 720. Thymic epithelial cells use macroautophagy to turn their inside out for CD4 T cell tolerance.
Autophagy 2013; 9 (6): 931-2
*23548947* 23548947 PMC3672302 721. PIK3C3/VPS34, the class III PtdIns 3-kinase, plays indispensable roles in the podocyte.
Autophagy 2013; 9 (6): 923-4 jchen@gru.edu
*23518611* 23518611 PMC3672297 722. Autophagy facilitates organelle clearance during differentiation of human erythroblasts: evidence for a role for ATG4 paralogs during autophagosome maturation.
Autophagy 2013; 9 (6): 881-93
*23508006* 23508006 PMC3672294 723. Autophagy in stem cells.
Autophagy 2013; 9 (6): 830-49 lguan@umich.edu
*23486312* 23486312 PMC3672296 724. Endosome-mediated autophagy: an unconventional MIIC-driven autophagic pathway operational in dendritic cells.
Autophagy 2013; 9 (6): 861-80
*23481895* 23481895 PMC3672293 725. The emerging role of acetylation in the regulation of autophagy.
Autophagy 2013; 9 (6): 819-29 abanreti@gmail.com
*23466676* 23466676 PMC3672300 726. Syntaxin 17: the autophagosomal SNARE.
Autophagy 2013; 9 (6): 917-9
*23466629* 23466629 PMC4069857 727. Mirror neurons are central for a second-person neuroscience: insights from developmental studies.
Behav Brain Sci 2013; 36 (4): 438 simpsonea@mail.nih.gov
*23883767* 23883767 PMC3713412 728. Role of the calcium-sensing receptor in calcium regulation of epidermal differentiation and function.
Best Pract Res Clin Endocrinol Metab 2013; 27 (3): 415-27
*23856269* 23856269 PMC3713417 729. The calcium-sensing receptor in the breast.
Best Pract Res Clin Endocrinol Metab 2013; 27 (3): 403-14 joshua.vanhouten@yale.edu
*23856268* 23856268 PMC3834352 730. Managing lupus patients during pregnancy.
Best Pract Res Clin Rheumatol 2013; 27 (3): 435-47 aisha_lateef@nuhs.edu.sg.
*24238698* 24238698 PMC3927537 731. Cutaneous lupus erythematosus: diagnosis and treatment.
Best Pract Res Clin Rheumatol 2013; 27 (3): 391-404
*24238695* 24238695 PMC4043121 732. Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis.
Biochem Biophys Res Commun 2013; 438 (2): 257-63 julien.gonzalez@inserm.fr
*23872063* 23872063 PMC4048943 733. Characterization of Dkk1 gene regulation by the osteoblast-specific transcription factor Osx.
Biochem Biophys Res Commun 2012; 420 (4): 782-6 Chi5.Zhang@utsouthwestern.edu
*22459449* 22459449 PMC4041335 734. Sclerostin is a direct target of osteoblast-specific transcription factor osterix.
Biochem Biophys Res Commun 2010; 400 (4): 684-8
*20816666* 20816666 PMC4056987 735. Cohesin: a critical chromatin organizer in mammalian gene regulation.
Biochem Cell Biol 2011; 89 (5): 445-58
*21851156* 21851156 PMC4040966 736. PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress.
Biochem J 2013; 451 (3): 375-88
*23421427* 23421427 PMC4049159 737. Intestinal absorption of water-soluble vitamins in health and disease.
Biochem J 2011; 437 (3): 357-72 hmsaid@uci.edu
*21749321* 21749321 PMC4072126 738. Responses of hypertrophied myocytes to reactive species: implications for glycolysis and electrophile metabolism.
Biochem J 2011; 435 (2): 519-28
*21275902* 21275902 PMC4062342 739. Insights into complexity of congenital disorders of glycosylation.
Biochem Med (Zagreb) 2012; 22 (2): 156-70 sandras@pharma.hr
*22838182* 22838182 PMC4062335 740. Analysis of censored data.
Biochem Med (Zagreb) 2012; 22 (2): 151-5 markolucijanic@yahoo.com
*22838181* 22838181 PMC4062322 741. Non-commutability of results of highly sensitive troponin I and T immunoassays.
Biochem Med (Zagreb) 2012; 22 (1): 127-9 glippi@ao.pr.it
*22384528* 22384528 PMC4062321 742. Inflammation and haemostasis.
Biochem Med (Zagreb) 2012; 22 (1): 49-62 sandra.margetic1@zg.t-com.hr
*22384519* 22384519 PMC4062318 743. Biomedical research platforms and their influence on article submissions and journal rankings: an update.
Biochem Med (Zagreb) 2012; 22 (1): 7-14
*22384515* 22384515 PMC4074543 744. Protein structure in context: the molecular landscape of angiogenesis.
Biochem Mol Biol Educ 2013; 41 (4): 213-23
*23868376* 23868376 PMC4076147 745. Optobiology: optical control of biological processes via protein engineering.
Biochem Soc Trans 2013; 41 (5): 1183-8
*24059506* 24059506 PMC4059518 746. Inverse solvent isotope effects arising from substrate triggering in the factor inhibiting hypoxia inducible factor.
Biochemistry 2013; 52 (9): 1594-602
*23351038* 23351038 PMC3674197 747. Sum of the parts: mass spectrometry-based metabolomics.
Biochemistry 2013; 52 (22): 3829-40
*23442130* 23442130 PMC3864574 748. Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping.
Biochemistry 2013; 52 (22): 3818-28
*23259809* 23259809 PMC4074459 749. Straight-chain alkyl isocyanides open the distal histidine gate in crystal structures of myoglobin .
Biochemistry 2010; 49 (24): 4977-86
*20481504* 20481504 PMC4067055 750. Cholesterol's interfacial interactions with galactosylceramides.
Biochemistry 1994; 33 (10): 2900-6
*8130203* 8130203 PMC3996523 751. Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway.
Biochim Biophys Acta 2014; 1843 (6): 1162-71 p.ferretti@ucl.ac.uk.
*24607566* 24607566 PMC3996726 752. miR-206 controls LXRalpha expression and promotes LXR-mediated cholesterol efflux in macrophages.
Biochim Biophys Acta 2014; 1841 (6): 827-35 Gerhard.kostner@medunigraz.at.
*24603323* 24603323 PMC4059559 753. Role of the -PEWY-glutamate in catalysis at the Q(o)-site of the Cyt bc(1) complex.
Biochim Biophys Acta 2013; 1827 (3): 365-86
*23123515* 23123515 PMC3742305 754. XRN 5'-->3' exoribonucleases: structure, mechanisms and functions.
Biochim Biophys Acta 2013; 1829 (6-7): 590-603
*23517755* 23517755 PMC3660545 755. Regulation of nonsense-mediated mRNA decay: implications for physiology and disease.
Biochim Biophys Acta 2013; 1829 (6-7): 624-33
*23500037* 23500037 PMC3752887 756. Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.
Biochim Biophys Acta 2013; 1829 (6-7): 666-79
*23428348* 23428348 PMC3660425 757. Structural and functional control of the eukaryotic mRNA decapping machinery.
Biochim Biophys Acta 2013; 1829 (6-7): 580-9
*23287066* 23287066 PMC3632658 758. Interplay between viruses and host mRNA degradation.
Biochim Biophys Acta 2013; 1829 (6-7): 732-41 krnaraya@utmb.edu
*23274304* 23274304 PMC3644320 759. Kiss your tail goodbye: the role of PARN, Nocturnin, and Angel deadenylases in mRNA biology.
Biochim Biophys Acta 2013; 1829 (6-7): 571-9
*23274303* 23274303 PMC3664190 760. Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation.
Biochim Biophys Acta 2013; 1829 (6-7): 680-8
*23246978* 23246978 PMC3631109 761. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Biochim Biophys Acta 2013; 1833 (6): 1454-62
*23466866* 23466866 PMC3625923 762. Real-time attack of LL-37 on single Bacillus subtilis cells.
Biochim Biophys Acta 2013; 1828 (6): 1511-20 barns@wisc.edu
*23454084* 23454084 PMC3674504 763. Disulfide reduction abolishes tissue factor cofactor function.
Biochim Biophys Acta 2013; 1830 (6): 3489-96
*23434438* 23434438 PMC3672862 764. Natural products: a continuing source of novel drug leads.
Biochim Biophys Acta 2013; 1830 (6): 3670-95
*23428572* 23428572 PMC4076288 765. Lysophospholipid receptor activation of RhoA and lipid signaling pathways.
Biochim Biophys Acta 2013; 1831 (1): 213-22
*22986288* 22986288 PMC4041949 766. Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-kappaB transcriptional activity by preventing p65 de-acetylation.
Biochim Biophys Acta 2013; 1833 (8): 1985-91 Tiina.Kauppinen@med.umanitoba.ca
*23597856* 23597856 PMC4048856 767. Hepcidin and iron homeostasis.
Biochim Biophys Acta 2012; 1823 (9): 1434-43 TGanz@mednet.ucla.edu
*22306005* 22306005 PMC4059211 768. Histone modifying enzymes: structures, mechanisms, and specificities.
Biochim Biophys Acta 2009; 1789 (1): 58-68
*18722564* 18722564 PMC4076010 769. The molecular mechanism and cellular functions of mitochondrial division.
Biochim Biophys Acta 2009; 1792 (12): 1138-44
*19100831* 19100831 PMC3684451 770. The serum- and glucocorticoid-induced protein kinase-1 (Sgk-1) mitochondria connection: identification of the IF-1 inhibitor of the F(1)F(0)-ATPase as a mitochondria-specific binding target and the stress-induced mitochondrial localization of endogenous Sgk-1.
Biochimie 2013; 95 (6): 1258-65
*23402912* 23402912 PMC3910495 771. Inducing cancer cell death by targeting its nucleus: solid gold nanospheres versus hollow gold nanocages.
Bioconjug Chem 2013; 24 (6): 897-906
*23777334* 23777334 PMC4070098 772. An adaptive permutation approach for genome-wide association study: evaluation and recommendations for use.
BioData Min 2014; 7 (ä): 9
*24976866* 24976866 PMC4031428 773. The Supertree Toolkit 2: a new and improved software package with a Graphical User Interface for supertree construction.
Biodivers Data J 2014; ä (2): e1053
*24891820* 24891820 PMC4058948 774. Large scale analysis of signal reachability.
Bioinformatics 2014; 30 (12): i96-104
*24932011* 24932011 PMC4058945 775. Robust clinical outcome prediction based on Bayesian analysis of transcriptional profiles and prior causal networks.
Bioinformatics 2014; 30 (12): i69-77
*24932007* 24932007 PMC4059059 776. Using association rule mining to determine promising secondary phenotyping hypotheses.
Bioinformatics 2014; 30 (12): i52-59
*24932005* 24932005 PMC4058954 777. Inferring gene ontologies from pairwise similarity data.
Bioinformatics 2014; 30 (12): i34-42
*24932003* 24932003 PMC4058956 778. AlignGraph: algorithm for secondary de novo genome assembly guided by closely related references.
Bioinformatics 2014; 30 (12): i319-i328
*24932000* 24932000 PMC4058950 779. Stochastic EM-based TFBS motif discovery with MITSU.
Bioinformatics 2014; 30 (12): i310-8
*24931999* 24931999 PMC4058952 780. New directions for diffusion-based network prediction of protein function: incorporating pathways with confidence.
Bioinformatics 2014; 30 (12): i219-27
*24931987* 24931987 PMC4058944 781. Probabilistic method for detecting copy number variation in a fetal genome using maternal plasma sequencing.
Bioinformatics 2014; 30 (12): i212-8
*24931986* 24931986 PMC4058951 782. Detecting independent and recurrent copy number aberrations using interval graphs.
Bioinformatics 2014; 30 (12): i195-203
*24931984* 24931984 PMC4058943 783. MIRA: mutual information-based reporter algorithm for metabolic networks.
Bioinformatics 2014; 30 (12): i175-84
*24931981* 24931981 PMC4058957 784. Metabolite identification through multiple kernel learning on fragmentation trees.
Bioinformatics 2014; 30 (12): i157-64
*24931979* 24931979
PMC4055613 897. Radiopharmaceutical stem cell tracking for neurological diseases.
Biomed Res Int 2014; 2014 (ä): 417091
*24982880* 24982880 PMC4055298 898. Bioinformatic prediction of WSSV-host protein-protein interaction.
Biomed Res Int 2014; 2014 (ä): 416543
*24982879* 24982879 PMC4058194 899. Simulated annealing based algorithm for identifying mutated driver pathways in cancer.
Biomed Res Int 2014; 2014 (ä): 375980
*24982873* 24982873 PMC4055073 900. Detection of gunshot residues using mass spectrometry.
Biomed Res Int 2014; 2014 (ä): 965403
*24977168* 24977168 PMC4054839 901. Animal toxins and their advantages in biotechnology and pharmacology.
Biomed Res Int 2014; 2014 (ä): 951561
*24977166* 24977166 PMC4055574 902. Pfetin as a risk factor of recurrence in gastrointestinal stromal tumors.
Biomed Res Int 2014; 2014 (ä): 651935
*24977158* 24977158 PMC4058174 903. enDNA-Prot: identification of DNA-binding proteins by applying ensemble learning.
Biomed Res Int 2014; 2014 (ä): 294279
*24977146* 24977146 PMC4058175 904. Propeller flaps: a review of indications, technique, and results.
Biomed Res Int 2014; 2014 (ä): 986829
*24971367* 24971367 PMC4058177 905. Percutaneous extraction of transvenous permanent pacemaker/defibrillator leads.
Biomed Res Int 2014; 2014 (ä): 949785
*24971363* 24971363 PMC4055143 906. Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat: focus on serum, urine, gene, and protein renal expression biomarkers.
Biomed Res Int 2014; 2014 (ä): 576929
*24971338* 24971338 PMC4054971 907. Toxicology of metals and metalloids.
Biomed Res Int 2014; 2014 (ä): 253738
*24971326* 24971326 PMC4055243 908. Local overexpression of V1a-vasopressin receptor enhances regeneration in tumor necrosis factor-induced muscle atrophy.
Biomed Res Int 2014; 2014 (ä): 235426
*24971321* 24971321 PMC4058196 909. Omics technologies and neovascular ocular disorders.
Biomed Res Int 2014; 2014 (ä): 231348
*24971319* 24971319 PMC4055360 910. May Renal Resistive Index be an early predictive tool of postoperative complications in major surgery? Preliminary results.
Biomed Res Int 2014; 2014 (ä): 917985
*24967414* 24967414 PMC4054801 911. Sunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.
Biomed Res Int 2014; 2014 (ä): 901371
*24967411* 24967411 PMC4055292 912. AmalgamScope: merging annotations data across the human genome.
Biomed Res Int 2014; 2014 (ä): 893501
*24967409* 24967409 PMC4055139 913. A priori knowledge and probability density based segmentation method for medical CT image sequences.
Biomed Res Int 2014; 2014 (ä): 769751
*24967402* 24967402 PMC4055362 914. To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.
Biomed Res Int 2014; 2014 (ä): 628597
*24967389* 24967389 PMC4022258 915. Human cytomegalovirus and autoimmune disease.
Biomed Res Int 2014; 2014 (ä): 472978
*24967373* 24967373 PMC4055245 916. Salvage therapy of multiple myeloma: the new generation drugs.
Biomed Res Int 2014; 2014 (ä): 456037
*24967371* 24967371 PMC4054680 917. Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go.
Biomed Res Int 2014; 2014 (ä): 435983
*24967369* 24967369 PMC4055497 918. Value of plasmatic membrane attack complex as a marker of severity in acute kidney injury.
Biomed Res Int 2014; 2014 (ä): 361065
*24967359* 24967359 PMC4055392 919. The technological development of minimally invasive spine surgery.
Biomed Res Int 2014; 2014 (ä): 293582
*24967347* 24967347 PMC4017845 920. Robotic upper limb rehabilitation after acute stroke by NeReBot: evaluation of treatment costs.
Biomed Res Int 2014; 2014 (ä): 265634
*24967345* 24967345 PMC4055366 921. Human aqueous humor levels of TGF- beta2: relationship with axial length.
Biomed Res Int 2014; 2014 (ä): 258591
*24967344* 24967344 PMC4054852 922. CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat.
Biomed Res Int 2014; 2014 (ä): 971750
*24963491* 24963491 PMC4052612 923. Identifying dynamic protein complexes based on gene expression profiles and PPI networks.
Biomed Res Int 2014; 2014 (ä): 375262
*24963481* 24963481 PMC4053230 924. Preliminary experience with small animal SPECT imaging on clinical gamma cameras.
Biomed Res Int 2014; 2014 (ä): 369509
*24963478* 24963478 PMC4055545 925. Sensitivities, specificities, and predictive values of microbiological culture techniques for the diagnosis of prosthetic joint infection.
Biomed Res Int 2014; 2014 (ä): 180416
*24963476* 24963476 PMC4055162 926. Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells.
Biomed Res Int 2014; 2014 (ä): 179486
*24963475* 24963475 PMC4053217 927. VEGF and eNOS expression in umbilical cord from pregnancy complicated by hypertensive disorder with different severity.
Biomed Res Int 2014; 2014 (ä): 982159
*24959596* 24959596 PMC4052068 928. Heart failure in patients with chronic kidney disease: a systematic integrative review.
Biomed Res Int 2014; 2014 (ä): 937398
*24959595* 24959595 PMC4052165 929. Total and free serum sialic acid concentration in liver diseases.
Biomed Res Int 2014; 2014 (ä): 876096
*24959592* 24959592 PMC4052159 930. BLAT-based comparative analysis for transposable elements: BLATCAT.
Biomed Res Int 2014; 2014 (ä): 730814
*24959585* 24959585 PMC4052155 931. Genotoxicity of microcystin-LR in in vitro and in vivo experimental models.
Biomed Res Int 2014; 2014 (ä): 949521
*24955368* 24955368 PMC4052930 932. Chondroitin sulfate proteoglycans: structure-function relationship with implication in neural development and brain disorders.
Biomed Res Int 2014; 2014 (ä): 642798
*24955366* 24955366 PMC4052087 933. Antiviral perspectives for chikungunya virus.
Biomed Res Int 2014; 2014 (ä): 631642
*24955364* 24955364 PMC4052685 934. Clinical genetics of Alzheimer's disease.
Biomed Res Int 2014; 2014 (ä): 291862
*24955352* 24955352 PMC4052113 935. NGS nominated CELA1, HSPG2, and KCNK5 as candidate genes for predisposition to Balkan endemic nephropathy.
Biomed Res Int 2014; 2014 (ä): 920723
*24949484* 24949484 PMC4037612 936. Novel molecular biomarkers at the blood-brain barrier in ALS.
Biomed Res Int 2014; 2014 (ä): 907545
*24949481* 24949481 PMC4052154 937. Endoscopic evacuation of basal ganglia hemorrhage via keyhole approach using an adjustable cannula in comparison with craniotomy.
Biomed Res Int 2014; 2014 (ä): 898762
*24949476* 24949476 PMC4037609 938. Benchmarking B-cell epitope prediction with quantitative dose-response data on antipeptide antibodies: towards novel pharmaceutical product development.
Biomed Res Int 2014; 2014 (ä): 867905
*24949474* 24949474 PMC4037623 939. Solanine induces mitochondria-mediated apoptosis in human pancreatic cancer cells.
Biomed Res Int 2014; 2014 (ä): 805926
*24949471* 24949471 PMC4052161 940. Gremlin activates the Smad pathway linked to epithelial mesenchymal transdifferentiation in cultured tubular epithelial cells.
Biomed Res Int 2014; 2014 (ä): 802841
*24949470* 24949470 PMC4052469 941. Extracellular matrix modulates angiogenesis in physiological and pathological conditions.
Biomed Res Int 2014; 2014 (ä): 756078
*24949467* 24949467 PMC4052120 942. Current and emerging biomarkers of cell death in human disease.
Biomed Res Int 2014; 2014 (ä): 690103
*24949464* 24949464 PMC4052075 943. A fast, reliable, and sensitive method for detection and quantification of Listeria monocytogenes and Escherichia coli O157:H7 in ready-to-eat fresh-cut products by MPN-qPCR.
Biomed Res Int 2014; 2014 (ä): 608296
*24949460* 24949460 PMC4052943 944. Punicalagin and ellagic acid demonstrate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adducts.
Biomed Res Int 2014; 2014 (ä): 467465
*24949451* 24949451 PMC4052501 945. Role of microRNA-1 in human cancer and its therapeutic potentials.
Biomed Res Int 2014; 2014 (ä): 428371
*24949449* 24949449 PMC4052700 946. The analysis of genetic aberrations in children with inherited neurometabolic and neurodevelopmental disorders.
Biomed Res Int 2014; 2014 (ä): 424796
*24949445* 24949445 PMC4052470 947. Are proteinase 3 and cathepsin C enzymes related to pathogenesis of periodontitis?
Biomed Res Int 2014; 2014 (ä): 420830
*24949444* 24949444 PMC4052072 948. Chagas' disease: pregnancy and congenital transmission.
Biomed Res Int 2014; 2014 (ä): 401864
*24949443* 24949443 PMC4052150 949. Circulating endothelial cells and chronic kidney disease.
Biomed Res Int 2014; 2014 (ä): 364738
*24949439* 24949439 PMC4052551 950. Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interaction.
Biomed Res Int 2014; 2014 (ä): 340216
*24949434* 24949434 PMC4052615 951. A systematic analysis of miRNA-mRNA paired variations reveals widespread miRNA misregulation in breast cancer.
Biomed Res Int 2014; 2014 (ä): 291280
*24949432* 24949432 PMC4053081 952. A network biology approach to discover the molecular biomarker associated with hepatocellular carcinoma.
Biomed Res Int 2014; 2014 (ä): 278956
*24949431* 24949431 PMC4052151 953. Autophagy in Drosophila: from historical studies to current knowledge.
Biomed Res Int 2014; 2014 (ä): 273473
*24949430* 24949430 PMC4052814 954. Tools and databases of the KOMICS web portal for preprocessing, mining, and dissemination of metabolomics data.
Biomed Res Int 2014; 2014 (ä): 194812
*24949426* 24949426 PMC4037588 955. O18Quant: a semiautomatic strategy for quantitative analysis of high-resolution 16O/18O labeled data.
Biomed Res Int 2014; 2014 (ä): 971857
*24901003* 24901003 PMC4034657 956. New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease.
Biomed Res Int 2014; 2014 (ä): 942960
*24901002* 24901002 PMC4034515 957. Topography prediction of helical transmembrane proteins by a new modification of the sliding window method.
Biomed Res Int 2014; 2014 (ä): 921218
*24900999* 24900999 PMC4034482 958. Evidence for bladder urothelial pathophysiology in functional bladder disorders.
Biomed Res Int 2014; 2014 (ä): 865463
*24900993* 24900993 PMC4037590 959. Physical therapy in wound healing, edema, and urinary incontinence.
Biomed Res Int 2014; 2014 (ä): 825826
*24900989* 24900989 PMC4034404 960. Multidisciplinary management of hepatocellular carcinoma in clinical practice.
Biomed Res Int 2014; 2014 (ä): 806391
*24900987* 24900987 PMC4036600 961. Morphohistological features of pancreatic stump are the main determinant of pancreatic fistula after pancreatoduodenectomy.
Biomed Res Int 2014; 2014 (ä): 641239
*24900974* 24900974 PMC4037596 962. Computational study to determine when to initiate and alternate therapy in HIV infection.
Biomed Res Int 2014; 2014 (ä): 472869
*24900966* 24900966 PMC4036408 963. Nonsteroidal anti-inflammatory drugs and prostatic diseases.
Biomed Res Int 2014; 2014 (ä): 436123
*24900965* 24900965 PMC4036431 964. Microsurgical techniques used to construct the vascularized and neurotized tissue engineered bone.
Biomed Res Int 2014; 2014 (ä): 281872
*24900962* 24900962 PMC4036418 965. Translational neuroimaging of the mood and anxiety disorders.
Biomed Res Int 2014; 2014 (ä): 240769
*24900956* 24900956 PMC4036420 966. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
Biomed Res Int 2014; 2014 (ä): 175062
*24900954* 24900954 PMC4026963 967. High-intensity physical training in the treatment of chronic diseases and disorders.
Biomed Res Int 2014; 2014 (ä): 927304
*24895628* 24895628 PMC4033593 968. A reliable method for rhythm analysis during cardiopulmonary resuscitation.
Biomed Res Int 2014; 2014 (ä): 872470
*24895621* 24895621 PMC4026877 969. Application of proteomics and peptidomics to COPD.
Biomed Res Int 2014; 2014 (ä): 764581
*24895607* 24895607 PMC4034507 970. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention.
Biomed Res Int 2014; 2014 (ä): 741018
*24895606* 24895606 PMC4033425 971. Timing embryo segmentation: dynamics and regulatory mechanisms of the vertebrate segmentation clock.
Biomed Res Int 2014; 2014 (ä): 718683
*24895605* 24895605 PMC4033420 972. Multiple regression analysis of mRNA-miRNA associations in colorectal cancer pathway.
Biomed Res Int 2014; 2014 (ä): 676724
*24895601* 24895601 PMC4034401 973. Glycoprotein IIb/IIIa inhibitors use and outcome after percutaneous coronary intervention for non-ST elevation myocardial infarction.
Biomed Res Int 2014; 2014 (ä): 643981
*24895595* 24895595 PMC4034406 974. Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy.
Biomed Res Int 2014; 2014 (ä): 595493
*24895592* 24895592 PMC4033392 975. Network of microRNAs-mRNAs interactions in pancreatic cancer.
Biomed Res Int 2014; 2014 (ä): 534821
*24895587* 24895587 PMC4034486 976. Platelet function tests: a review of progresses in clinical application.
Biomed Res Int 2014; 2014 (ä): 456569
*24895576* 24895576 PMC4033431 977. Neovaginal prolapse in male-to-female transsexuals: an 18-year-long experience.
Biomed Res Int 2014; 2014 (ä): 240761
*24895556* 24895556 PMC4034396 978. Impact of hemodialysis on dyspnea and lung function in end stage kidney disease patients.
Biomed Res Int 2014; 2014 (ä): 212751
*24895552* 24895552 PMC4026875 979. Fatty acids in energy metabolism of the central nervous system.
Biomed Res Int 2014; 2014 (ä): 472459
*24883315* 24883315 PMC4026940 980. A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries.
Biomed Res Int 2014; 2014 (ä): 428619
*24883312* 24883312 PMC4026945 981. Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction.
Biomed Res Int 2014; 2014 (ä): 376191
*24883308* 24883308 PMC4026914 982. Calorie restriction in mammals and simple model organisms.
Biomed Res Int 2014; 2014 (ä): 308690
*24883306* 24883306 PMC4026919 983. The role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target?
Biomed Res Int 2014; 2014 (ä): 301575
*24883305* 24883305 PMC4026921 984. Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.
Biomed Res Int 2014; 2014 (ä): 251479
*24883303* 24883303 PMC4026869 985. Pathway-driven discovery of rare mutational impact on cancer.
Biomed Res Int 2014; 2014 (ä): 171892
*24883302* 24883302 PMC3864982 986. Bayesian spatial transformation models with applications in neuroimaging data.
Biometrics 2013; 69 (4): 1074-83
*24128143* 24128143 PMC4059083 987. Multiple imputation in quantile regression.
Biometrika 2012; 99 (2): 423-438
*24944347* 24944347 PMC3702567 988. Parallel generation of uniform fine droplets at hundreds of kilohertz in a flow-focusing module.
Biomicrofluidics 2013; 7 (3): 34112
*24404032* 24404032 PMC4030989 989. Re-configuration of sphingolipid metabolism by oncogenic transformation.
Biomolecules 2014; 4 (1): 315-53 anthonyd@unsw.edu.au.;
*24970218* 24970218 PMC4030979 990. Long noncoding RNAs in imprinting and X chromosome inactivation.
Biomolecules 2014; 4 (1): 76-100 jautuoro@gmail.com.;
*24970206* 24970206 PMC4030981 991. Microbial enzymes: tools for biotechnological processes.
Biomolecules 2014; 4 (1): 117-39 jladrio@neolbio.com.;
*24970208* 24970208 PMC4030978 992. Effect of metals on kinetic pathways of amyloid-beta aggregation.
Biomolecules 2014; 4 (1): 101-16 francishane@gmail.com.;
*24970207* 24970207 PMC4030994 993. Heavy metals and metalloids as a cause for protein misfolding and aggregation.
Biomolecules 2014; 4 (1): 252-67 markus.tamas@cmb.gu.se.;
*24970215* 24970215 PMC4030991 994. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.
Biomolecules 2014; 4 (1): 235-51 yamahiro@tokai-u.jp.;
*24970214* 24970214 PMC4030948 995. Quantum mechanical modeling: a tool for the understanding of enzyme reactions.
Biomolecules 2013; 3 (3): 662-702 naraysza@chem.elte.hu.;
*24970187* 24970187 PMC4030971 996. Improvement of biocatalysts for industrial and environmental purposes by saturation mutagenesis.
Biomolecules 2013; 3 (4): 778-811 gianfranco.gilardi@unito.it.
*24970191* 24970191 PMC4030973 997. Biotechnological applications of transglutaminases.
Biomolecules 2013; 3 (4): 870-88 natalca.rachel@gmail.com.;
*24970194* 24970194 PMC4030974 998. Biocatalysis for biobased chemicals.
Biomolecules 2013; 3 (4): 812-47 ruben_de_regil@yahoo.com.;
*24970192* 24970192 PMC4030975 999. Research applications of proteolytic enzymes in molecular biology.
Biomolecules 2013; 3 (4): 923-42 motyan.janos@med.unideb.hu.;
*24970197* 24970197 PMC4030964 1000. Control of cell differentiation by mitochondria, typically evidenced in dictyostelium development.
Biomolecules 2013; 3 (4): 943-66 kjygy352@ybb.ne.jp.;
*24970198* 24970198 PMC4030976 1001. Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.
Biomolecules 2013; 3 (4): 889-904 gds11@pitt.edu.;
*24970195* 24970195 PMC4030969 1002. Control of Collagen Stability and Heterotrimer Specificity through Repulsive Electrostatic Interactions.
Biomolecules 2013; 3 (4): 986-96 parmar@cabm.rutgers.edu.;
*24970200* 24970200 PMC4030986 1003. Misfolding of amyloidogenic proteins and their interactions with membranes.
Biomolecules 2013; 4 (1): 20-55 relini@fisica.unige.it.;
*24970204* 24970204 PMC4030985 1004. The role of non-native interactions in the folding of knotted proteins: insights from molecular dynamics simulations.
Biomolecules 2013; 4 (1): 1-19 faccioli@science.unitn.it.;
*24970203* 24970203 PMC4030947 1005. Microbial enzymes with special characteristics for biotechnological applications.
Biomolecules 2013; 3 (3): 597-611 p.singh@ulster.ac.uk.
*24970183* 24970183 PMC4030956 1006. A sensitive DNA enzyme-based fluorescent assay for bacterial detection.
Biomolecules 2013; 3 (3): 563-77 sergio.aguirre454@gmail.com.;
*24970181* 24970181 PMC4030944 1007. Carbonic anhydrases and their biotechnological applications.
Biomolecules 2013; 3 (3): 553-62 cdboone@ufl.edu.;
*24970180* 24970180 PMC4030949 1008. The impact of sphingosine kinase-1 in head and neck cancer.
Biomolecules 2013; 3 (3): 481-513 pyamada@cc.hawaii.edu.;
*24970177* 24970177
PMC4030848 1009. Sphingosine 1-phosphate and cancer: lessons from thyroid cancer cells.
Biomolecules 2013; 3 (2): 303-15 ktornqvi@abo.fi.
*24970169* 24970169 PMC4030851 1010. The roles of sphingosine kinase 1 and 2 in regulating the metabolome and survival of prostate cancer cells.
Biomolecules 2013; 3 (2): 316-33 f.tonelli@dundee.ac.uk.;
*24970170* 24970170 PMC4030952 1011. Altered sphingolipid metabolism in patients with metastatic pancreatic cancer.
Biomolecules 2013; 3 (3): 435-48 yjiang@umd.edu.;
*24970174* 24970174 PMC4030958 1012. Regulation of cytoskeleton organization by sphingosine in a mouse cell model of progressive ovarian cancer.
Biomolecules 2013; 3 (3): 386-407 acreekmo@iupui.edu.;
*24970173* 24970173 PMC4030880 1013. Role of the checkpoint clamp in DNA damage response.
Biomolecules 2013; 3 (1): 75-84 mkai2@jhmi.edu.
*24970157* 24970157 PMC4030889 1014. Why YRNAs? About Versatile RNAs and Their Functions.
Biomolecules 2013; 3 (1): 143-56 marcel.koehn@medizin.uni-halle.de.;
*24970161* 24970161 PMC4030888 1015. Regulation of Mammalian Gene Dosage by Long Noncoding RNAs.
Biomolecules 2013; 3 (1): 124-42 khung@sanfordburnham.org.;
*24970160* 24970160 PMC4030883 1016. Panning for Long Noncoding RNAs.
Biomolecules 2013; 3 (1): 226-41 zhushanshan@picb.ac.cn.;
*24970166* 24970166 PMC4030886 1017. Recent advances in cellular glycomic analyses.
Biomolecules 2013; 3 (1): 198-225 yshinohara@sci.hokudai.ac.jp.
*24970165* 24970165 PMC4030878 1018. Multi-Color Spectral Transcript Analysis (SPECTRA) for Phenotypic Characterization of Tumor Cells.
Biomolecules 2013; 3 (1): 180-97 jhhsu11@gmail.com.;
*24970164* 24970164 PMC4030849 1019. Single Nucleotide Polymorphisms Associated with MicroRNA Regulation.
Biomolecules 2013; 3 (2): 287-302 g0901870@nus.edu.sg.;
*24970168* 24970168 PMC4030838 1020. Sumoylation and the DNA damage response.
Biomolecules 2012; 2 (3): 376-88 catherine.cremona@cancer.org.uk
*24926426* 24926426 PMC4030860 1021. Sialyl-tn in cancer: (how) did we miss the target?
Biomolecules 2012; 2 (4): 435-66 sylvain.julien@univ-lille1.fr.;
*24970145* 24970145 PMC4030857 1022. Pathways for genome integrity in G2 phase of the cell cycle.
Biomolecules 2012; 2 (4): 579-607 ank@bric.ku.dk.;
*24970150* 24970150 PMC4030864 1023. Functional Aspects of PARP1 in DNA Repair and Transcription.
Biomolecules 2012; 2 (4): 524-48 Ko_Huiling@immunol.a-star.edu.sg.;
*24970148* 24970148 PMC4030840 1024. From phosphorous to arsenic: changing the classic paradigm for the structure of biomolecules.
Biomolecules 2012; 2 (2): 282-7 knodle@rams.colostate.edu.;
*24970138* 24970138 PMC4030845 1025. DeSUMOylation Controls Insulin Exocytosis in Response to Metabolic Signals.
Biomolecules 2012; 2 (2): 269-81 elisa.vergari@ocdem.ox.ac.uk.;
*24970137* 24970137 PMC4030841 1026. Regulation of Neuronal Protein Trafficking and Translocation by SUMOylation.
Biomolecules 2012; 2 (2): 256-68 J.M.Henley@bristol.ac.uk.
*24970136* 24970136 PMC4030869 1027. Endoplasmic reticulum calcium pumps and cancer cell differentiation.
Biomolecules 2012; 2 (1): 165-86 belapapp2@yahoo.fr.;
*24970132* 24970132 PMC4030843 1028. Cell penetrating peptides in the delivery of biopharmaceuticals.
Biomolecules 2012; 2 (2): 187-202 munyendollw@yahoo.com.;
*24970133* 24970133 PMC4030873 1029. Mortalin, apoptosis, and neurodegeneration.
Biomolecules 2012; 2 (1): 143-64 londonop@email.unc.edu.;
*24970131* 24970131 PMC4030836 1030. SUMO Wrestles with Recombination.
Biomolecules 2012; 2 (3): 350-75 77543@mail.muni.cz.;
*24970142* 24970142 PMC4030865 1031. A New Method to Determine Antigen-Specific CD8+ T Cell Activity in Vivo by Hydrodynamic Injection.
Biomolecules 2012; 2 (1): 23-33 urai@adarc.org.;
*24970125* 24970125 PMC4030867 1032. Fucosylation is a promising target for cancer diagnosis and therapy.
Biomolecules 2012; 2 (1): 34-45 emiyoshi@sahs.med.osaka-u.ac.jp.;
*24970126* 24970126 PMC4030870 1033. Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.
Biomolecules 2012; 2 (1): 46-75 anne.braunschweig@hki-jena.de.;
*24970127* 24970127 PMC4030866 1034. Oxysterols and their cellular effectors.
Biomolecules 2012; 2 (1): 76-103 vesa.olkkonen@helsinki.fi.;
*24970128* 24970128 PMC4030885 1035. Homologous recombination as a replication fork escort: fork-protection and recovery.
Biomolecules 2012; 3 (1): 39-71 Audrey.costes@curie.fr.;
*24970156* 24970156 PMC4030884 1036. Molecular Insights into Poly(ADP-ribose) Recognition and Processing.
Biomolecules 2012; 3 (1): 1-17 mikoc@irb.hr.;
*24970154* 24970154 PMC4030856 1037. Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy.
Biomolecules 2012; 2 (4): 635-49 cecilia.strom@scilifelab.se.;
*24970153* 24970153 PMC4030844 1038. The Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer.
Biomolecules 2012; 2 (2): 240-55 pvlacho@med.uth.gr.;
*24970135* 24970135 PMC4030829 1039. Ursolic Acid Inhibits Na+/K+-ATPase Activity and Prevents TNF-alpha-Induced Gene Expression by Blocking Amino Acid Transport and Cellular Protein Synthesis.
Biomolecules 2011; 1 (1): 32-47 yokkon424@yahoo.co.jp.;
*24970122* 24970122 PMC4034589 1040. Leveraging systems biology approaches in clinical pharmacology.
Biopharm Drug Dispos 2013; 34 (9): 477-88
*23983165* 23983165 PMC3672866 1041. Examination of the subsarcolemmal tubular system of mammalian skeletal muscle fibers.
Biophys J 2013; 104 (11): L19-21
*23746530* 23746530 PMC3672864 1042. Fracture mechanics of collagen fibrils: influence of natural cross-links.
Biophys J 2013; 104 (11): 2476-84 svensson.nano@gmail.com
*23746520* 23746520 PMC3672867 1043. Cholesterol translocation in a phospholipid membrane.
Biophys J 2013; 104 (11): 2429-36
*23746515* 23746515 PMC3672899 1044. A membrane-translocating peptide penetrates into bilayers without significant bilayer perturbations.
Biophys J 2013; 104 (11): 2419-28
*23746514* 23746514 PMC3672897 1045. The mechanism of Na(+)/K(+) selectivity in mammalian voltage-gated sodium channels based on molecular dynamics simulation.
Biophys J 2013; 104 (11): 2401-9
*23746512* 23746512 PMC3672901 1046. Modeling stochastic kinetics of molecular machines at multiple levels: from molecules to modules.
Biophys J 2013; 104 (11): 2331-41 debch@iitk.ac.in
*23746505* 23746505 PMC3672905 1047. Superresolution imaging--caveolae, caveolins, mitochondria, and function in heart.
Biophys J 2013; 104 (11): 2323 jlederer@umaryland.edu
*23746501* 23746501 PMC3686354 1048. Thermal mechanisms of millimeter wave stimulation of excitable cells.
Biophys J 2013; 104 (12): 2622-8 mikhail@caltech.edu
*23790370* 23790370 PMC3686343 1049. Systems biophysics of gene expression.
Biophys J 2013; 104 (12): 2574-85 j.vilar@ikerbasque.org
*23790365* 23790365 PMC3728174 1050. Computer Simulations of the Bacterial Cytoplasm.
Biophys Rev 2013; 5 (2): 109-119
*23914257* 23914257 PMC3659821 1051. Simulation and Modeling of Crowding Effects on the Thermodynamic and Kinetic Properties of Proteins with Atomic Details.
Biophys Rev 2013; 5 (2): 207-215
*23710260* 23710260 PMC3652485 1052. Analytical Ultracentrifugation as a Tool for Studying Protein Interactions.
Biophys Rev 2013; 5 (2): 159-171
*23682298* 23682298 PMC4046743 1053. A review of international biobanks and networks: success factors and key benchmarks.
Biopreserv Biobank 2009; 7 (3): 143-50
*24835880* 24835880 PMC4034332 1054. Comparison of the accuracy and mechanism of data mining identification of the intestinal microbiota with 7 restriction enzymes.
Biosci Microbiota Food Health 2013; 32 (4): 139-48
*24936373* 24936373 PMC3596473 1055. Selective virus detection in complex sample matrices with photonic crystal optical cavities.
Biosens Bioelectron 2013; 44 (ä): 229-34
*23434758* 23434758 PMC4070022 1056. Advances in repairing the degenerate retina by rod photoreceptor transplantation.
Biotechnol Adv 2014; 32 (2): 485-91 rachael.pearson@ucl.ac.uk.
*24412415* 24412415 PMC4073797 1057. Thermodynamic analysis of biodegradation pathways.
Biotechnol Bioeng 2009; 103 (3): 532-41
*19288443* 19288443 PMC4057815 1058. Chlorella for protein and biofuels: from strain selection to outdoor cultivation in a Green Wall Panel photobioreactor.
Biotechnol Biofuels 2014; 7 (ä): 84
*24932216* 24932216 PMC4033574 1059. The centrality of RNA for engineering gene expression.
Biotechnol J 2013; 8 (12): 1379-95
*24124015* 24124015 PMC4075121 1060. Enzyme-etching technique to fabricate micropatterns of aligned collagen fibrils.
Biotechnol Lett 2014; 36 (6): 1245-52
*24562408* 24562408 PMC4041869 1061. Tendon and ligament regeneration and repair: clinical relevance and developmental paradigm.
Birth Defects Res C Embryo Today 2013; 99 (3): 203-222
*24078497* 24078497 PMC4046425 1062. Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children.
Blood 2014; 123 (21): 3221-9
*24596418* 24596418 PMC4064334 1063. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.
Blood 2014; 123 (25): 3979-87
*24740810* 24740810 PMC3674661 1064. Extracellular microRNAs turn on NK cells via TLR1.
Blood 2013; 121 (23): 4612-3
*23744491* 23744491 PMC3674667 1065. MicroRNAs activate natural killer cells through Toll-like receptor signaling.
Blood 2013; 121 (23): 4663-71
*23580661* 23580661 PMC3695368 1066. Coordinate expression of transcripts and proteins in platelets.
Blood 2013; 121 (26): 5255-6
*23813941* 23813941 PMC3689252 1067. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.
Blood 2013; 121 (25): 5098-103
*23547053* 23547053 PMC3682336 1068. Long noncoding RNAs in biology and hematopoiesis.
Blood 2013; 121 (24): 4842-6
*23645840* 23645840 PMC3682335 1069. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
Blood 2013; 121 (24): 4821-31
*23589674* 23589674 PMC4042303 1070. Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma.
Blood Cancer J 2014; 4 (ä): e213
*24813081* 24813081 PMC4042302 1071. TALEN-mediated genetic tailoring as a tool to analyze the function of acquired mutations in multiple myeloma cells.
Blood Cancer J 2014; 4 (ä): e210
*24813078* 24813078 PMC4042299 1072. The role of epigenetics in the biology of multiple myeloma.
Blood Cancer J 2014; 4 (ä): e207
*24786391* 24786391 PMC4044801 1073. The Italian National Centre for Rare Diseases: where research and public health translate into action.
Blood Transfus 2014; 12 Suppl 3 (ä): s591-605
*24922300* 24922300 PMC4044803 1074. Current status of Italian Registries on inherited bleeding disorders.
Blood Transfus 2014; 12 Suppl 3 (ä): s576-81
*24922298* 24922298 PMC4044810 1075. Current and evolving features in the clinical management of haemophilia.
Blood Transfus 2014; 12 Suppl 3 (ä): s554-62
*24922295* 24922295 PMC4044796 1076. The European Haemophilia Network (EUHANET).
Blood Transfus 2014; 12 Suppl 3 (ä): s515-8
*24922291* 24922291 PMC4052286 1077. Investigating perturbed pathway modules from gene expression data via structural equation models.
BMC Bioinformatics 2014; 15 (ä): 132 danielepepe84@gmail.com.
*24885496* 24885496 PMC4071222 1078. BicSPAM: flexible biclustering using sequential patterns.
BMC Bioinformatics 2014; 15 (ä): 130 rmch@tecnico.ulisboa.pt.
*24885271* 24885271 PMC4062517 1079. BLASTGrabber: a bioinformatic tool for visualization, analysis and sequence selection of massive BLAST data.
BMC Bioinformatics 2014; 15 (ä): 128 kamran@ibv.uio.no.
*24885091* 24885091 PMC4055234 1080. Population genetic analysis of bi-allelic structural variants from low-coverage sequence data with an expectation-maximization algorithm.
BMC Bioinformatics 2014; 15 (ä): 163 lucas.lledo@igb-berlin.de.
*24884587* 24884587 PMC4053266 1081. A multivariate approach to the integration of multi-omics datasets.
BMC Bioinformatics 2014; 15 (ä): 162 aedin@jimmy.harvard.edu.
*24884486* 24884486 PMC4062501 1082. A resource-saving collective approach to biomedical semantic role labeling.
BMC Bioinformatics 2014; 15 (ä): 160 thtsai@csie.ncu.edu.tw.
*24884358* 24884358 PMC4064501 1083. KRLMM: an adaptive genotype calling method for common and low frequency variants.
BMC Bioinformatics 2014; 15 (ä): 158 rafa@jimmy.harvard.edu.
*24886250* 24886250 PMC4046016 1084. Multidimensional mutual information methods for the analysis of covariation in multiple sequence alignments.
BMC Bioinformatics 2014; 15 (ä): 157 e.tillier@utoronto.ca.
*24886131* 24886131 PMC4035737 1085. In silico evaluation of the influence of the translocon on partitioning of membrane segments.
BMC Bioinformatics 2014; 15 (ä): 156 dominique.tessier@nantes.inra.fr.
*24885988* 24885988 PMC4035752 1086. Combining calls from multiple somatic mutation-callers.
BMC Bioinformatics 2014; 15 (ä): 154 suyeonkim08@gmail.com.
*24885750* 24885750 PMC4035826 1087. Improving the sensitivity of sample clustering by leveraging gene co-expression networks in variable selection.
BMC Bioinformatics 2014; 15 (ä): 153 yin.liu@uth.tmc.edu.
*24885641* 24885641 PMC4046174 1088. The discriminant power of RNA features for pre-miRNA recognition.
BMC Bioinformatics 2014; 15 (ä): 124 ivani.negrao@embrapa.br.
*24884650* 24884650 PMC4033618 1089. A formal concept analysis approach to consensus clustering of multi-experiment expression data.
BMC Bioinformatics 2014; 15 (ä): 151 anna.hristoskova@intec.ugent.be.
*24885407* 24885407 PMC4035852 1090. Improvement of domain-level ortholog clustering by optimizing domain-specific sum-of-pairs score.
BMC Bioinformatics 2014; 15 (ä): 148 uchiyama@nibb.ac.jp.
*24885064* 24885064 PMC4064103 1091. A fast and robust iterative algorithm for prediction of RNA pseudoknotted secondary structures.
BMC Bioinformatics 2014; 15 (ä): 147 hjabbari@cs.ubc.ca.
*24884954* 24884954 PMC4030446 1092. Efficient discovery of responses of proteins to compounds using active learning.
BMC Bioinformatics 2014; 15 (ä): 143 murphy@cmu.edu.
*24884564* 24884564 PMC4046028 1093. DMRforPairs: identifying differentially methylated regions between unique samples using array based methylation profiles.
BMC Bioinformatics 2014; 15 (ä): 141 l.looijenga@erasmusmc.nl.
*24884391* 24884391 PMC4030460 1094. Ciruvis: a web-based tool for rule networks and interaction detection using rule-based classifiers.
BMC Bioinformatics 2014; 15 (ä): 139 jan.komorowski@icm.uu.se.
*24886370* 24886370 PMC4067983 1095. mrSNP: software to detect SNP effects on microRNA binding.
BMC Bioinformatics 2014; 15 (ä): 73 mdeveci@bmi.osu.edu.
*24629096* 24629096 PMC4063228 1096. QMachine: commodity supercomputing in web browsers.
BMC Bioinformatics 2014; 15 (ä): 176 wilkinson@uab.edu.
*24913605* 24913605 PMC4067372 1097. Scan for Motifs: a webserver for the analysis of post-transcriptional regulatory elements in the 3' untranslated regions (3' UTRs) of mRNAs.
BMC Bioinformatics 2014; 15 (ä): 174 chris.brown@otago.ac.nz.
*24909639* 24909639 PMC4068973 1098. MiningABs: mining associated biomarkers across multi-connected gene expression datasets.
BMC Bioinformatics 2014; 15 (ä): 173 kafrazer@ucsd.edu.
*24909518* 24909518 PMC4069276 1099. hsphase: an R package for pedigree reconstruction, detection of recombination events, phasing and imputation of half-sib family groups.
BMC Bioinformatics 2014; 15 (ä): 172 mferdosi@myune.edu.au.
*24906803* 24906803 PMC4057934 1100. Scoring docking conformations using predicted protein interfaces.
BMC Bioinformatics 2014; 15 (ä): 171 Reyhaneh.Esmaielbeiki@dtc.ox.ac.uk.
*24906633* 24906633 PMC4061774 1101. Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences.
BMC Bioinformatics 2014; 15 (ä): 170 Paul.Boutros@oicr.on.ca.
*24902696* 24902696 PMC4063694 1102. A semi-automated technique for labeling and counting of apoptosing retinal cells.
BMC Bioinformatics 2014; 15 (ä): 169 m.cordeiro@ucl.ac.uk.
*24902592* 24902592 PMC4063226 1103. PVT: an efficient computational procedure to speed up next-generation sequence analysis.
BMC Bioinformatics 2014; 15 (ä): 167 zhumur@jcbose.ac.in.
*24894600* 24894600 PMC4061105 1104. On the necessity of dissecting sequence similarity scores into segment-specific contributions for inferring protein homology, function prediction and annotation.
BMC Bioinformatics 2014; 15 (ä): 166 wongwc@bii.a-star.edu.sg.
*24890864* 24890864 PMC4071796 1105. Automated peptide mapping and protein-topographical annotation of proteomics data.
BMC Bioinformatics 2014; 15 (ä): 207 oliver.schilling@mol-med.uni-freiburg.de.
*24946880* 24946880 PMC4071023 1106. CIRCUS: a package for Circos display of structural genome variations from paired-end and mate-pair sequencing data.
BMC Bioinformatics 2014; 15 (ä): 198 delphine.naquin@cgm.cnrs-gif.fr.
*24938393* 24938393 PMC4071799 1107. KVFinder: steered identification of protein cavities as a PyMOL plugin.
BMC Bioinformatics 2014; 15 (ä): 197 paulo.oliveira@lnbio.cnpem.br.
*24938294* 24938294 PMC4073188 1108. Online GESS: prediction of miRNA-like off-target effects in large-scale RNAi screen data by seed region analysis.
BMC Bioinformatics 2014; 15 (ä): 192 stephanie_mohr@hms.harvard.edu.
*24934636* 24934636 PMC4065607 1109. Efficient design of meganucleases using a machine learning approach.
BMC Bioinformatics 2014; 15 (ä): 191 philippe.duchateau@cellectis.com.
*24934562* 24934562 PMC4067528 1110. An integrative method to normalize RNA-Seq data.
BMC Bioinformatics 2014; 15 (ä): 188 daniel.petit@unilim.fr.
*24929920* 24929920 PMC4065584 1111. Assessment and refinement of eukaryotic gene structure prediction with gene-structure-aware multiple protein sequence alignment.
BMC Bioinformatics 2014; 15 (ä): 189 o.gotoh@aist.go.jp.
*24927652* 24927652 PMC4049470 1112. Accelerating the scoring module of mass spectrometry-based peptide identification using GPUs.
BMC Bioinformatics 2014; 15 (ä): 121 chxw@comp.hkbu.edu.hk.
*24773593* 24773593 PMC4038116 1113. On finding bicliques in bipartite graphs: a novel algorithm and its application to the integration of diverse biological data types.
BMC Bioinformatics 2014; 15 (ä): 110 langston@eecs.utk.edu.
*24731198* 24731198 PMC4015449 1114. MetaSel: a metaphase selection tool using a Gaussian-based classification technique.
BMC Bioinformatics 2013; 14 Suppl 16 (ä): S13
*24564477* 24564477 PMC4067946 1115. iVUN: interactive Visualization of Uncertain biochemical reaction Networks.
BMC Bioinformatics 2013; 14 Suppl 19 (ä): S2
*24564335* 24564335 PMC4068752 1116. Molecular dissection of Wnt3a-Frizzled8 interaction reveals essential and modulatory determinants of Wnt signaling activity.
BMC Biol 2014; 12 (ä): 44 suat.oezbek@cos.uni-heidelberg.de.
*24885675* 24885675 PMC4071339 1117. BMP2-induced chemotaxis requires PI3K p55gamma/p110alpha-dependent phosphatidylinositol (3,4,5)-triphosphate production and LL5beta recruitment at the cytocortex.
BMC Biol 2014; 12 (ä): 43 Knaus@zedat.fu-berlin.de.
*24885555* 24885555 PMC4071332 1118. RNA-seq: impact of RNA degradation on transcript quantification.
BMC Biol 2014; 12 (ä): 42 gilad@uchicago.edu.
*24885439* 24885439 PMC4046053 1119. Casposons: a new superfamily of self-synthesizing DNA transposons at the origin of prokaryotic CRISPR-Cas immunity.
BMC Biol 2014; 12 (ä): 36 krupovic@pasteur.fr.
*24884953* 24884953 PMC4064517 1120. Hmga2 is required for canonical WNT signaling during lung development.
BMC Biol 2014; 12 (ä): 21 guillermo.barreto@mpi-bn.mpg.de.
*24661562* 24661562
PMC4057613 1121. Altered glutamyl-aminopeptidase activity and expression in renal neoplasms.
BMC Cancer 2014; 14 (ä): 386 gorka.larrinaga@ehu.es.
*24885240* 24885240 PMC4045915 1122. Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.
BMC Cancer 2014; 14 (ä): 354 ruddella@uw.edu.
*24886322* 24886322 PMC4062892 1123. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
BMC Cancer 2014; 14 (ä): 393 hongyun_jia@163.com.
*24890815* 24890815 PMC4074405 1124. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
BMC Cancer 2014; 14 (ä): 450 yangjilong@tjmuch.com.
*24942472* 24942472 PMC4072613 1125. Tyrosine phosphorylation profiling via in situ proximity ligation assay.
BMC Cancer 2014; 14 (ä): 435 sara.lind@kemi.uu.se.
*24928687* 24928687 PMC4072609 1126. Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim.
BMC Cancer 2014; 14 (ä): 431 kangbh@unist.ac.kr.
*24927938* 24927938 PMC4059455 1127. Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells.
BMC Cell Biol 2014; 15 (ä): 21 wluis@bahia.fiocruz.br.
*24915973* 24915973 PMC4070356 1128. Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy.
BMC Complement Altern Med 2014; 14 (ä): 195 ddqstrike@163.com.
*24942185* 24942185 PMC4067084 1129. Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review.
BMC Endocr Disord 2014; 14 (ä): 49 khowa002@umn.edu.
*24934576* 24934576 PMC4046058 1130. Ectopic insulin secreting neuroendocrine tumor of kidney with recurrent hypoglycemia: a diagnostic dilemma.
BMC Endocr Disord 2014; 14 (ä): 36 vivekapjyotsna@yahoo.com.
*24741994* 24741994 PMC4061511 1131. Mother and offspring fitness in an insect with maternal care: phenotypic trade-offs between egg number, egg mass and egg care.
BMC Evol Biol 2014; 14 (ä): 125 meunier.joel@gmail.com.
*24913927* 24913927 PMC4061927 1132. Treatment of acute pancreatitis with protease inhibitors administered through intravenous infusion: an updated systematic review and meta-analysis.
BMC Gastroenterol 2014; 14 (ä): 102 t-nakayama@umin.ac.jp.
*24886242* 24886242 PMC4035071 1133. XSAnno: a framework for building ortholog models in cross-species transcriptome comparisons.
BMC Genomics 2014; 15 (ä): 343 nenad.sestan@yale.edu.
*24884593* 24884593 PMC4035064 1134. MicroRNA profiling of rats with ochratoxin A nephrotoxicity.
BMC Genomics 2014; 15 (ä): 333 xuwentao@cau.edu.cn.
*24885635* 24885635 PMC4048458 1135. Genetic distance as an alternative to physical distance for definition of gene units in association studies.
BMC Genomics 2014; 15 (ä): 408 antonio.gonzalez.martinez-pedrayo@sergas.es.
*24884992* 24884992 PMC4045971 1136. Selective and flexible depletion of problematic sequences from RNA-seq libraries at the cDNA stage.
BMC Genomics 2014; 15 (ä): 401 thomas.preiss@anu.edu.au.
*24886553* 24886553 PMC4041998 1137. Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells.
BMC Genomics 2014; 15 (ä): 395 valerie.courgnaud@igmm.cnrs.fr.
*24885883* 24885883 PMC4057610 1138. GAP-Seq: a method for identification of DNA palindromes.
BMC Genomics 2014; 15 (ä): 394 strathej@mail.nih.gov.
*24885769* 24885769 PMC4070555 1139. REGNET: mining context-specific human transcription networks using composite genomic information.
BMC Genomics 2014; 15 (ä): 450 kimsy@kribb.re.kr.
*24912499* 24912499 PMC4070549 1140. CAP-miRSeq: a comprehensive analysis pipeline for microRNA sequencing data.
BMC Genomics 2014; 15 (ä): 423 sun.zhifu@mayo.edu.
*24894665* 24894665 PMC4070569 1141. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling.
BMC Genomics 2014; 15 (ä): 419 cperou@med.unc.edu.
*24888378* 24888378 PMC4053652 1142. Direct observation of genomic heterogeneity through local haplotyping analysis.
BMC Genomics 2014; 15 (ä): 418 kgulukota@northshore.org.
*24888354* 24888354 PMC4070571 1143. Identification of candidate long non-coding RNAs in response to myocardial infarction.
BMC Genomics 2014; 15 (ä): 460 yvan.devaux@crp-sante.lu.
*24917243* 24917243 PMC4061446 1144. EFIN: predicting the functional impact of nonsynonymous single nucleotide polymorphisms in human genome.
BMC Genomics 2014; 15 (ä): 455 yangwl@hkucc.hku.hk.
*24916671* 24916671 PMC4051124 1145. HGCS: an online tool for prioritizing disease-causing gene variants by biological distance.
BMC Genomics 2014; 15 (ä): 256 yitan@rockefeller.edu.
*24694260* 24694260 PMC4046711 1146. Sequence alignment by passing messages.
BMC Genomics 2014; 15 Suppl 1 (ä): S14
*24564436* 24564436 PMC4046714 1147. MetaCluster-TA: taxonomic annotation for metagenomic data based on assembly-assisted binning.
BMC Genomics 2014; 15 Suppl 1 (ä): S12
*24564377* 24564377 PMC4046680 1148. Supervised categorical principal component analysis for genome-wide association analyses.
BMC Genomics 2014; 15 Suppl 1 (ä): S10
*24564304* 24564304 PMC4046823 1149. An improved ChIP-seq peak detection system for simultaneously identifying post-translational modified transcription factors by combinatorial fusion, using SUMOylation as an example.
BMC Genomics 2014; 15 Suppl 1 (ä): S1
*24564277* 24564277 PMC4046818 1150. Genetic control of renal tumorigenesis by the mouse Rtm1 locus.
BMC Genomics 2013; 14 (ä): 724 olga.ibanez@butantan.gov.br.
*24148528* 24148528 PMC4046676 1151. Pseudo-Sanger sequencing: massively parallel production of long and near error-free reads using NGS technology.
BMC Genomics 2013; 14 (ä): 711 luxm@big.ac.cn.
*24134808* 24134808 PMC4046693 1152. CEG: a database of essential gene clusters.
BMC Genomics 2013; 14 (ä): 769 fbguo@uestc.edu.cn.
*24209780* 24209780 PMC4046673 1153. SPIEDw: a searchable platform-independent expression database web tool.
BMC Genomics 2013; 14 (ä): 765 gareth.2.williams@kcl.ac.uk.
*24199845* 24199845 PMC4046663 1154. Life based on phosphite: a genome-guided analysis of Desulfotignum phosphitoxidans.
BMC Genomics 2013; 14 (ä): 753 Diliana.Simeonova@uni-konstanz.de.
*24180241* 24180241 PMC4046740 1155. A platform independent RNA-Seq protocol for the detection of transcriptome complexity.
BMC Genomics 2013; 14 (ä): 855 apollonia.tullo@ba.itb.cnr.it.
*24308330* 24308330 PMC4042239 1156. Post genome-wide association studies functional characterization of prostate cancer risk loci.
BMC Genomics 2013; 14 Suppl 8 (ä): S9
*24564736* 24564736 PMC4042241 1157. Simultaneous inferences based on empirical Bayes methods and false discovery rates ineQTL data analysis.
BMC Genomics 2013; 14 Suppl 8 (ä): S8
*24564682* 24564682 PMC4046566 1158. Molecular pathway identification using biological network-regularized logistic models.
BMC Genomics 2013; 14 Suppl 8 (ä): S7
*24564637* 24564637 PMC4042237 1159. Identification of gene fusions from human lung cancer mass spectrometry data.
BMC Genomics 2013; 14 Suppl 8 (ä): S5
*24564548* 24564548 PMC4042266 1160. MetaID: a novel method for identification and quantification of metagenomic samples.
BMC Genomics 2013; 14 Suppl 8 (ä): S4
*24564518* 24564518 PMC4042236 1161. QChIPat: a quantitative method to identify distinct binding patterns for two biological ChIP-seq samples in different experimental conditions.
BMC Genomics 2013; 14 Suppl 8 (ä): S3
*24564479* 24564479 PMC4065311 1162. Diagnosis and early detection of CNS-SLE in MRL/lpr mice using peptide microarrays.
BMC Immunol 2014; 15 (ä): 23 swilli4@asu.edu.
*24908187* 24908187 PMC4071025 1163. IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis.
BMC Infect Dis 2014; 14 (ä): 336 zhangheqiu2004@126.com.
*24939009* 24939009 PMC4064821 1164. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
BMC Med 2014; 12 (ä): 81 mhzhao@bjmu.edu.cn.
*24884842* 24884842 PMC4053286 1165. Risk stratification in emergency patients by copeptin.
BMC Med 2014; 12 (ä): 80 kasper.iversen@dadlnet.dk.
*24884642* 24884642 PMC4054906 1166. Dark matter RNA illuminates the puzzle of genome-wide association studies.
BMC Med 2014; 12 (ä): 97 philipp@stlaurentinstitute.org.
*24924000* 24924000 PMC4063424 1167. Generating genius: how an Alzheimer's drug became considered a 'cognitive enhancer' for healthy individuals.
BMC Med Ethics 2014; 15 (ä): 37 eric.racine@ircm.qc.ca.
*24885270* 24885270 PMC4055375 1168. How do physicians decide to treat: an empirical evaluation of the threshold model.
BMC Med Inform Decis Mak 2014; 14 (ä): 47 bdjulbeg@health.usf.edu.
*24903517* 24903517 PMC4049370 1169. Network-meta analysis made easy: detection of inconsistency using factorial analysis-of-variance models.
BMC Med Res Methodol 2014; 14 (ä): 61 hans-peter.piepho@uni-hohenheim.de.
*24885590* 24885590 PMC4065386 1170. The oxygen sensor MgFnr controls magnetite biomineralization by regulation of denitrification in Magnetospirillum gryphiswaldense.
BMC Microbiol 2014; 14 (ä): 153 dirk.schueler@uni-bayreuth.de.
*24915802* 24915802 PMC4059090 1171. Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation.
BMC Musculoskelet Disord 2014; 15 (ä): 184 Melanie.Timmen@ukmuenster.de.
*24885217* 24885217 PMC4048624 1172. Incidence, histopathologic analysis and distribution of tumours of the hand.
BMC Musculoskelet Disord 2014; 15 (ä): 182 amling@uke.de.
*24885007* 24885007 PMC4042140 1173. Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort.
BMC Musculoskelet Disord 2014; 15 (ä): 174 i.meek@reuma.umcn.nl.
*24886363* 24886363 PMC4064102 1174. Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.
BMC Nephrol 2014; 15 (ä): 87 bjorn.meijers@uzleuven.be.
*24912660* 24912660 PMC4071327 1175. Safety and tissue yield for percutaneous native kidney biopsy according to practitioner and ultrasound technique.
BMC Nephrol 2014; 15 (ä): 96 imkidney@catholic.ac.kr.
*24957046* 24957046 PMC4062516 1176. Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipients.
BMC Nephrol 2014; 15 (ä): 88 cjmeaney@buffalo.edu.
*24925208* 24925208 PMC4039987 1177. Glass ionomer ART sealant and fluoride-releasing resin sealant in fissure caries prevention--results from a randomized clinical trial.
BMC Oral Health 2014; 14 (ä): 54 smilelby@hku.hk.
*24886444* 24886444 PMC4029480 1178. Erosive and cariogenicity potential of pediatric drugs: study of physicochemical parameters.
BMC Oral Health 2013; 13 (ä): 71 alidianne.fabia@gmail.com.
*24325544* 24325544 PMC4029320 1179. The impact of structural diversity and parameterization on maps of the protein universe.
BMC Proc 2013; 7 (Suppl 7): S1
*24565442* 24565442 PMC4044484 1180. BiCluE - Exact and heuristic algorithms for weighted bi-cluster editing of biomedical data.
BMC Proc 2013; 7 (Suppl 7): S9
*24565035* 24565035 PMC4044883 1181. MicroRNA identification using linear dimensionality reduction with explicit feature mapping.
BMC Proc 2013; 7 (Suppl 7): S8
*24564997* 24564997 PMC4043421 1182. Adaptive bandwidth kernel density estimation for next-generation sequencing data.
BMC Proc 2013; 7 (Suppl 7): S7
*24564977* 24564977 PMC4043987 1183. Multi-task feature selection in microarray data by binary integer programming.
BMC Proc 2013; 7 (Suppl 7): S5
*24564944* 24564944 PMC4044206 1184. Better primer design for metagenomics applications by increasing taxonomic distinguishability.
BMC Proc 2013; 7 (Suppl 7): S4
*24564926* 24564926 PMC4042834 1185. Conceptualization of molecular findings by mining gene annotations.
BMC Proc 2013; 7 (Suppl 7): S2
*24564884* 24564884 PMC4051165 1186. Ensemble-based classification approach for micro-RNA mining applied on diverse metagenomic sequences.
BMC Res Notes 2014; 7 (ä): 286 sherin.elgokhy@ejust.edu.eg.
*24884968* 24884968 PMC4045924 1187. GFF-Ex: a genome feature extraction package.
BMC Res Notes 2014; 7 (ä): 315 dinesh@icgeb.res.in.
*24885931* 24885931 PMC4048252 1188. A method for generating highly multiplexed ChIP-seq libraries.
BMC Res Notes 2014; 7 (ä): 312 thanos@bioacademy.gr.
*24885602* 24885602 PMC4041147 1189. A model reduction method for biochemical reaction networks.
BMC Syst Biol 2014; 8 (ä): 52 b.jayawardhana@rug.nl.
*24885656* 24885656 PMC4045882 1190. MP-Align: alignment of metabolic pathways.
BMC Syst Biol 2014; 8 (ä): 58 merce.llabres@uib.es.
*24886436* 24886436 PMC4031158 1191. Network topology-based detection of differential gene regulation and regulatory switches in cell metabolism and signaling.
BMC Syst Biol 2014; 8 (ä): 56 r.koenig@dkfz.de.
*24886210* 24886210 PMC4049504 1192. TGF-beta stimulation in human and murine cells reveals commonly affected biological processes and pathways at transcription level.
BMC Syst Biol 2014; 8 (ä): 55 abnaof@bit.uni-bonn.de.
*24886091* 24886091 PMC4029543 1193. Inferring protein domains associated with drug side effects based on drug-target interaction network.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S18
*24565527* 24565527 PMC4029456 1194. Active enhancer positions can be accurately predicted from chromatin marks and collective sequence motif data.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S16
*24565409* 24565409 PMC4029529 1195. Multivariate generalized multifactor dimensionality reduction to detect gene-gene interactions.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S15
*24565370* 24565370 PMC4029527 1196. PPSampler2: predicting protein complexes more accurately and efficiently by sampling.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S14
*24565288* 24565288 PMC4029220 1197. Inferring functional transcription factor-gene binding pairs by integrating transcription factor binding data with transcription factor knockout data.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S13
*24565265* 24565265 PMC4028811 1198. Missing value imputation for microarray data: a comprehensive comparison study and a web tool.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S12
*24565220* 24565220 PMC4028886 1199. Shrinkage regression-based methods for microarray missing value imputation.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S11
*24565159* 24565159 PMC4029265 1200. CGPredictor: a systematic integrated analytic tool for mining and examining genome-scale cancer independent prognostic epigenetic marker panels.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S10
*24565108* 24565108 PMC4029488 1201. Identification of key regulators in glycogen utilization in E. coli based on the simulations from a hybrid functional Petri net model.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S1
*24565082* 24565082 PMC4029432 1202. PREAL: prediction of allergenic protein by maximum Relevance Minimum Redundancy (mRMR) feature selection.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S9
*24565053* 24565053 PMC4028860 1203. Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S8
*24565027* 24565027 PMC4028983 1204. Gene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinoma.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S7
*24564989* 24564989 PMC4029299 1205. Computational drug repositioning through heterogeneous network clustering.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S6
*24564976* 24564976 PMC4029547 1206. iSVP: an integrated structural variant calling pipeline from high-throughput sequencing data.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S8
*24564972* 24564972 PMC4029551 1207. OMACC: an Optical-Map-Assisted Contig Connector for improving de novo genome assembly.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S7
*24564959* 24564959 PMC4029357 1208. BRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S5
*24564956* 24564956 PMC4028818 1209. mAPC-GibbsOS: an integrated approach for robust identification of gene regulatory networks.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S4
*24564939* 24564939 PMC4028974 1210. A networks method for ranking microRNA dysregulation in cancer.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S3
*24564923* 24564923 PMC4029569 1211. Dynamic protein interaction modules in human hepatocellular carcinoma progression.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S2
*24564909* 24564909 PMC4029519 1212. An approach for dynamical network reconstruction of simple network motifs.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S4
*24564905* 24564905 PMC4029197 1213. GeneTopics--interpretation of gene sets via literature-driven topic models.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S10
*24564875* 24564875 PMC4029277 1214. Scalable prediction of compound-protein interactions using minwise hashing.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S3
*24564870* 24564870 PMC4029366 1215. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
BMC Syst Biol 2013; 7 Suppl 5 (ä): S1
*24564859* 24564859 PMC4029371 1216. KCF-S: KEGG Chemical Function and Substructure for improved interpretability and prediction in chemical bioinformatics.
BMC Syst Biol 2013; 7 Suppl 6 (ä): S2
*24564846* 24564846 PMC4046902 1217. Obama widens access to government funded research.
BMJ 2013; 346 (ä): f1339
*23449676* 23449676 PMC3448348 1218. Classic Bartter syndrome: a rare cause of failure to thrive in a child.
BMJ Case Rep 2012; 2012 (ä): ä hrvieira@gmail.com
*22744244* 22744244 PMC3387480 1219. Infant death due to CMV enterocolitis.
BMJ Case Rep 2012; 2012 (ä): ä zaferrefai@hotmail.com
*22707698* 22707698 PMC3831387 1220. Ultrasound-guided percutaneous antegrade hydropropulsion to relieve ureteral obstruction in a pet guinea pig (Cavia porcellus).
Can Vet J 2013; 54 (12): 1142-5
*24293674* 24293674 PMC4066392 1221. The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.
Cancer 2009; 115 (10): 2155-64 kyle.robert@mayo.edu
*19248045* 19248045 PMC3706087 1222. Cancer Stem Cells Activate STAT3 the EZ Way.
Cancer Cell 2013; 23 (6): 711-3
*23763996* 23763996 PMC3748274 1223. Hopping between differentiation states in lung adenocarcinoma.
Cancer Cell 2013; 23 (6): 707-9 hideo_watanabe@dfci.harvard.edu
*23763994* 23763994 PMC4068350 1224. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.
Cancer Cell 2012; 22 (1): 21-35
*22789536* 22789536 PMC3679355 1225. Canonical Wnt/beta-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.
Cancer Discov 2013; 3 (6): 674-89
*23535903* 23535903 PMC3864571 1226. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.
Cancer Discov 2013; 3 (12): 1364-77
*24078773* 24078773 PMC4051818 1227. Regulation of tumor growth and metastasis: the role of tumor microenvironment.
Cancer Growth Metastasis 2014; 7 (ä): 9-18
*24926201* 24926201 PMC3894696 1228. Review of ultrasonography of malignant neck nodes: greyscale, Doppler, contrast enhancement and elastography.
Cancer Imaging 2014; 13 (4): 658-69
*24434158* 24434158 PMC3800430 1229. Mimics of pancreatic ductal adenocarcinoma.
Cancer Imaging 2013; 13 (3): 342-9
*24060833* 24060833 PMC3858104 1230. Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board (part 1 of 2 part series).
Cancer Imaging 2013; 13 (3): 429-39
*24325900* 24325900 PMC3858864 1231. Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board: (part 2 of 2 part series).
Cancer Imaging 2013; 13 (3): 440-7
*24325879* 24325879 PMC3864167 1232. Progress on the diagnosis and evaluation of brain tumors.
Cancer Imaging 2013; 13 (4): 466-81
*24334439* 24334439
